activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1504931	CHEMBL831067	Inhibitory activity against Aurora kinase C	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	120.0	CHEMBL3935	Homo sapiens	IC50	nM	120.0
	1504931	CHEMBL831067	Inhibitory activity against Aurora kinase C	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	120.0	CHEMBL3935	Homo sapiens	IC50	nM	120.0
	1504933	CHEMBL827047	Inhibition of Aurora kinase C	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	120.0	CHEMBL3935	Homo sapiens	IC50	nM	120.0
Not Active	1650666	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1650667	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1650668	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3935	Homo sapiens	Kd		
	1650669	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	310.0	CHEMBL3935	Homo sapiens	Kd	uM	0.31
Not Active	1650670	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3935	Homo sapiens	Kd		
	1650671	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	3000.0	CHEMBL3935	Homo sapiens	Kd	uM	3.0
Not Active	1650672	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1650673	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1650674	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3935	Homo sapiens	Kd		
	1651115	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	11.0	CHEMBL3935	Homo sapiens	Kd	uM	0.011
Not Active	1651116	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1651117	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1651118	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1651119	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL3935	Homo sapiens	Kd		
	1651120	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	5300.0	CHEMBL3935	Homo sapiens	Kd	uM	5.3
Not Active	1651121	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1651122	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1651123	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Active	1651124	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL3935	Homo sapiens	Kd		
	1651125	CHEMBL860787	Average Binding Constant for Aurora3; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	3500.0	CHEMBL3935	Homo sapiens	Kd	uM	3.5
	1781985	CHEMBL911835	Inhibition of Aurora C kinase	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	61.0	CHEMBL3935	Homo sapiens	IC50	uM	0.061
	1790090	CHEMBL873733	In vitro inhibition constant for Aurora-C	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	umol	0.0046
	1790573	CHEMBL856429	Inhibition of human recombinant Aurora C-INCENP	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	17.0	CHEMBL3935	Homo sapiens	Ki	uM	0.017
	1915015	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	IC50	nM	300.0	CHEMBL3935	Homo sapiens	IC50	uM	0.3
	1915017	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=C1C(c2c(O)[nH]c3c(I)cccc23)=Nc2ccccc21		CHEMBL379160	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	1915018	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(I)cccc32)\Nc2ccccc2\1		CHEMBL395077	=	IC50	nM	28000.0	CHEMBL3935	Homo sapiens	IC50	uM	28.0
	1915019	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(I)cccc32)\Nc2ccccc2\1		CHEMBL244191	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	1915020	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=Nc1c(-c2c(O)[nH]c3c(I)cccc23)[nH]c2ccccc12		CHEMBL209648	=	IC50	nM	600.0	CHEMBL3935	Homo sapiens	IC50	uM	0.6
	1915021	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=C1C(c2c(O)[nH]c3c(F)cccc23)=Nc2ccccc21		CHEMBL210446	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	1915022	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(F)cccc32)\Nc2ccccc2\1		CHEMBL243985	=	IC50	nM	1000.0	CHEMBL3935	Homo sapiens	IC50	uM	1.0
	1915023	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(F)cccc32)\Nc2ccccc2\1		CHEMBL397720	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	1915024	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=Nc1c(-c2c(O)[nH]c3c(F)cccc23)[nH]c2ccccc12		CHEMBL212174	=	IC50	nM	1000.0	CHEMBL3935	Homo sapiens	IC50	uM	1.0
	1915025	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=C1C(c2c(O)[nH]c3c(Cl)cccc23)=Nc2ccccc21		CHEMBL378191	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	1915026	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(Cl)cccc32)\Nc2ccccc2\1		CHEMBL397719	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	1915027	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(Cl)cccc32)\Nc2ccccc2\1		CHEMBL243776	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	1915028	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=Nc1c(-c2c(O)[nH]c3c(Cl)cccc23)[nH]c2ccccc12		CHEMBL213650	=	IC50	nM	900.0	CHEMBL3935	Homo sapiens	IC50	uM	0.9
	1915029	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=C1C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21		CHEMBL214173	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	1915030	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(Br)cccc32)\Nc2ccccc2\1		CHEMBL395766	=	IC50	nM	4500.0	CHEMBL3935	Homo sapiens	IC50	uM	4.5
	1915031	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(Br)cccc32)\Nc2ccccc2\1		CHEMBL243556	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	1915032	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=Nc1c(-c2c(O)[nH]c3c(Br)cccc23)[nH]c2ccccc12		CHEMBL373834	=	IC50	nM	700.0	CHEMBL3935	Homo sapiens	IC50	uM	0.7
	1915033	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	IC50	nM	200.0	CHEMBL3935	Homo sapiens	IC50	uM	0.2
	1915034	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CC(=O)O/N=C1\C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21		CHEMBL209849	=	IC50	nM	700.0	CHEMBL3935	Homo sapiens	IC50	uM	0.7
	1915035	CHEMBL894339	Inhibition of human recombinant aurora C kinase	B	CO/N=C1\C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21		CHEMBL211243	=	IC50	nM	400.0	CHEMBL3935	Homo sapiens	IC50	uM	0.4
	1997523	CHEMBL899965	Inhibition of recombinant aurora C kinase	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL392525	=	IC50	nM	227.0	CHEMBL3935	Homo sapiens	IC50	uM	0.227
	2104574	CHEMBL931998	Inhibition of Aurora C kinase	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	2104577	CHEMBL931998	Inhibition of Aurora C kinase	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Ki	nM	61.0	CHEMBL3935	Homo sapiens	Ki	nM	61.0
	2206803	CHEMBL974019	Inhibition of Aurora C	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	310.0	CHEMBL3935	Homo sapiens	Kd	nM	310.0
	2206911	CHEMBL974019	Inhibition of Aurora C	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
Not Active	2302213	CHEMBL945706	Inhibition of human aurora C at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
	2396064	CHEMBL1006303	Inhibition of AURKC at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	45.0	CHEMBL3935	Homo sapiens	INH	%	45.0
	2470113	CHEMBL1032256	Inhibition of AURKC at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3935	Homo sapiens	INH	%	10.0
Not Evaluated	2476733	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3935	Homo sapiens	Activity		
Not Evaluated	2478572	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3935	Homo sapiens	Activity		
	2478775	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	0.9	CHEMBL3935	Homo sapiens	Activity	%	0.9
	2479581	CHEMBL1025768	Inhibition of AURC	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	2479630	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	12.5	CHEMBL3935	Homo sapiens	Activity	%	12.5
	2479833	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	1.7	CHEMBL3935	Homo sapiens	Activity	%	1.7
	2480630	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.5	CHEMBL3935	Homo sapiens	Activity	%	0.5
	2480832	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	3.4	CHEMBL3935	Homo sapiens	Activity	%	3.4
	2512030	CHEMBL970565	Inhibition of Aurora C at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	36.0	CHEMBL3935	Homo sapiens	INH	%	36.0
	2526354	CHEMBL993742	Inhibition of aurora C kinase	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	2526355	CHEMBL993742	Inhibition of aurora C kinase	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	IC50	nM	65.0	CHEMBL3935	Homo sapiens	IC50	nM	65.0
Not Evaluated	2577251	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3935	Homo sapiens	Activity		
Not Evaluated	2577454	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3935	Homo sapiens	Activity		
Not Evaluated	2593659	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL3935	Homo sapiens	Activity		
	2593925	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	32.9	CHEMBL3935	Homo sapiens	Activity	%	32.9
Not Evaluated	2594128	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL3935	Homo sapiens	Activity		
Not Evaluated	2594868	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3935	Homo sapiens	Activity		
Not Evaluated	2595071	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3935	Homo sapiens	Activity		
	2596268	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	2.0	CHEMBL3935	Homo sapiens	Activity	%	2.0
	2596471	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	29.7	CHEMBL3935	Homo sapiens	Activity	%	29.7
Not Evaluated	2597740	CHEMBL982761	Binding affinity to human AURC at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3935	Homo sapiens	Activity		
	2626907	CHEMBL999791	Binding affinity to human Aurora C at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Activity	%	75.0	CHEMBL3935	Homo sapiens	Activity	%	75.0
	2626934	CHEMBL999791	Binding affinity to human Aurora C at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	2635921	CHEMBL1004133	Inhibition of Aurora C at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	50.0	CHEMBL3935	Homo sapiens	Residual_activity	%	50.0
	2635989	CHEMBL1004133	Inhibition of Aurora C at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	<	Residual_activity	%	25.0	CHEMBL3935	Homo sapiens	Residual_activity	%	25.0
	2636057	CHEMBL1004133	Inhibition of Aurora C at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL3935	Homo sapiens	Residual_activity	%	75.0
	2644551	CHEMBL1031296	Inhibition of Aurora-C	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)n[nH]3)c3ccccc3n2)cc1		CHEMBL484950	=	Ki	nM	11.0	CHEMBL3935	Homo sapiens	Ki	nM	11.0
Antagonist	2897264	CHEMBL1051321	Inhibition of Aurora C in the presence of 100uM ATP	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	70.0	CHEMBL3935	Homo sapiens	IC50	uM	0.07
Antagonist	2897265	CHEMBL1062878	Inhibition of Aurora C in the presence of 5uM ATP	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	210.0	CHEMBL3935	Homo sapiens	IC50	uM	0.21
Antagonist	2897266	CHEMBL1062878	Inhibition of Aurora C in the presence of 5uM ATP	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	IC50	nM	17.0	CHEMBL3935	Homo sapiens	IC50	uM	0.017
Antagonist	2898357	CHEMBL1061992	Percentage Aurora C activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	27.0	CHEMBL3935	Homo sapiens	Activity	%	27.0
	2898358	CHEMBL1061992	Percentage Aurora C activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	2898359	CHEMBL1061992	Percentage Aurora C activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	71.0	CHEMBL3935	Homo sapiens	Activity	%	71.0
	2898360	CHEMBL1061948	Percentage Aurora C activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	76.0	CHEMBL3935	Homo sapiens	Activity	%	76.0
Antagonist	2898361	CHEMBL1061948	Percentage Aurora C activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	9.0	CHEMBL3935	Homo sapiens	Activity	%	9.0
	2898362	CHEMBL1061948	Percentage Aurora C activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	92.0	CHEMBL3935	Homo sapiens	Activity	%	92.0
	2898363	CHEMBL1061948	Percentage Aurora C activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	85.0	CHEMBL3935	Homo sapiens	Activity	%	85.0
	2898364	CHEMBL1061948	Percentage Aurora C activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	77.0	CHEMBL3935	Homo sapiens	Activity	%	77.0
Antagonist	2898365	CHEMBL1061948	Percentage Aurora C activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	44.0	CHEMBL3935	Homo sapiens	Activity	%	44.0
	2898366	CHEMBL1061948	Percentage Aurora C activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	92.0	CHEMBL3935	Homo sapiens	Activity	%	92.0
	2898367	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	96.0	CHEMBL3935	Homo sapiens	Activity	%	96.0
	2898368	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	118.0	CHEMBL3935	Homo sapiens	Activity	%	118.0
	2898369	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	84.0	CHEMBL3935	Homo sapiens	Activity	%	84.0
Antagonist	2898370	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	7.0	CHEMBL3935	Homo sapiens	Activity	%	7.0
	2898371	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	81.0	CHEMBL3935	Homo sapiens	Activity	%	81.0
	2898372	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	91.0	CHEMBL3935	Homo sapiens	Activity	%	91.0
	2898373	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	84.0	CHEMBL3935	Homo sapiens	Activity	%	84.0
Antagonist	2898374	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	48.0	CHEMBL3935	Homo sapiens	Activity	%	48.0
	2898375	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	54.0	CHEMBL3935	Homo sapiens	Activity	%	54.0
	2898376	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	83.0	CHEMBL3935	Homo sapiens	Activity	%	83.0
	2898377	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	70.0	CHEMBL3935	Homo sapiens	Activity	%	70.0
	2898378	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	77.0	CHEMBL3935	Homo sapiens	Activity	%	77.0
	2898379	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	73.0	CHEMBL3935	Homo sapiens	Activity	%	73.0
	2898380	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	66.0	CHEMBL3935	Homo sapiens	Activity	%	66.0
	2898381	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	70.0	CHEMBL3935	Homo sapiens	Activity	%	70.0
	2898382	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	56.0	CHEMBL3935	Homo sapiens	Activity	%	56.0
	2898383	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	74.0	CHEMBL3935	Homo sapiens	Activity	%	74.0
	2898384	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	85.0	CHEMBL3935	Homo sapiens	Activity	%	85.0
Antagonist	2898385	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	34.0	CHEMBL3935	Homo sapiens	Activity	%	34.0
	2898386	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	77.0	CHEMBL3935	Homo sapiens	Activity	%	77.0
	2898387	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	80.0	CHEMBL3935	Homo sapiens	Activity	%	80.0
	2898388	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	80.0	CHEMBL3935	Homo sapiens	Activity	%	80.0
	2898389	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	88.0	CHEMBL3935	Homo sapiens	Activity	%	88.0
	2898390	CHEMBL1061993	Percentage Aurora C activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	66.0	CHEMBL3935	Homo sapiens	Activity	%	66.0
	2898391	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	78.0	CHEMBL3935	Homo sapiens	Activity	%	78.0
	2898392	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	83.0	CHEMBL3935	Homo sapiens	Activity	%	83.0
	2898393	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	104.0	CHEMBL3935	Homo sapiens	Activity	%	104.0
Antagonist	2898394	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	8.0	CHEMBL3935	Homo sapiens	Activity	%	8.0
Antagonist	2898395	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	17.0	CHEMBL3935	Homo sapiens	Activity	%	17.0
Antagonist	2898396	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	10.0	CHEMBL3935	Homo sapiens	Activity	%	10.0
	2898397	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	82.0	CHEMBL3935	Homo sapiens	Activity	%	82.0
	2898398	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	92.0	CHEMBL3935	Homo sapiens	Activity	%	92.0
	2898399	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	82.0	CHEMBL3935	Homo sapiens	Activity	%	82.0
	2898400	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	69.0	CHEMBL3935	Homo sapiens	Activity	%	69.0
	2898401	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	96.0	CHEMBL3935	Homo sapiens	Activity	%	96.0
	2898402	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	76.0	CHEMBL3935	Homo sapiens	Activity	%	76.0
	2898403	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	83.0	CHEMBL3935	Homo sapiens	Activity	%	83.0
	2898404	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	68.0	CHEMBL3935	Homo sapiens	Activity	%	68.0
Antagonist	2898405	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	20.0	CHEMBL3935	Homo sapiens	Activity	%	20.0
	2898406	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	70.0	CHEMBL3935	Homo sapiens	Activity	%	70.0
	2898407	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	83.0	CHEMBL3935	Homo sapiens	Activity	%	83.0
	2898408	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	91.0	CHEMBL3935	Homo sapiens	Activity	%	91.0
	2898409	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	87.0	CHEMBL3935	Homo sapiens	Activity	%	87.0
	2898410	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	99.0	CHEMBL3935	Homo sapiens	Activity	%	99.0
	2898411	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	92.0	CHEMBL3935	Homo sapiens	Activity	%	92.0
	2898412	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	73.0	CHEMBL3935	Homo sapiens	Activity	%	73.0
Antagonist	2898413	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	20.0	CHEMBL3935	Homo sapiens	Activity	%	20.0
	2898414	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	57.0	CHEMBL3935	Homo sapiens	Activity	%	57.0
	2898415	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	88.0	CHEMBL3935	Homo sapiens	Activity	%	88.0
	2898416	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	83.0	CHEMBL3935	Homo sapiens	Activity	%	83.0
	2898417	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	76.0	CHEMBL3935	Homo sapiens	Activity	%	76.0
	2898418	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	97.0	CHEMBL3935	Homo sapiens	Activity	%	97.0
Antagonist	2898419	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	7.0	CHEMBL3935	Homo sapiens	Activity	%	7.0
Antagonist	2898420	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	21.0	CHEMBL3935	Homo sapiens	Activity	%	21.0
	2898421	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	71.0	CHEMBL3935	Homo sapiens	Activity	%	71.0
	2898422	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	75.0	CHEMBL3935	Homo sapiens	Activity	%	75.0
Antagonist	2898423	CHEMBL1062797	Percentage Aurora C activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	48.0	CHEMBL3935	Homo sapiens	Activity	%	48.0
	2898424	CHEMBL1052066	Percentage Aurora C activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	94.0	CHEMBL3935	Homo sapiens	Activity	%	94.0
	2898425	CHEMBL1052066	Percentage Aurora C activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	95.0	CHEMBL3935	Homo sapiens	Activity	%	95.0
	2898426	CHEMBL1062892	Percentage Aurora C activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	79.0	CHEMBL3935	Homo sapiens	Activity	%	79.0
	2898427	CHEMBL1051341	Percentage Aurora C activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	75.0	CHEMBL3935	Homo sapiens	Activity	%	75.0
	2903505	CHEMBL1060236	Binding constant for full-length AURKC	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	71.0	CHEMBL3935	Homo sapiens	Kd	nM	71.0
	2903506	CHEMBL1060236	Binding constant for full-length AURKC	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	1900.0	CHEMBL3935	Homo sapiens	Kd	nM	1900.0
	2903507	CHEMBL1060236	Binding constant for full-length AURKC	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	740.0	CHEMBL3935	Homo sapiens	Kd	nM	740.0
	2903508	CHEMBL1060236	Binding constant for full-length AURKC	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	4.4	CHEMBL3935	Homo sapiens	Kd	nM	4.4
	2903509	CHEMBL1060236	Binding constant for full-length AURKC	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903510	CHEMBL1060236	Binding constant for full-length AURKC	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903511	CHEMBL1060236	Binding constant for full-length AURKC	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1100.0	CHEMBL3935	Homo sapiens	Kd	nM	1100.0
	2903512	CHEMBL1060236	Binding constant for full-length AURKC	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903513	CHEMBL1060236	Binding constant for full-length AURKC	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2800.0	CHEMBL3935	Homo sapiens	Kd	nM	2800.0
	2903514	CHEMBL1060236	Binding constant for full-length AURKC	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903515	CHEMBL1060236	Binding constant for full-length AURKC	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903516	CHEMBL1060236	Binding constant for full-length AURKC	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903517	CHEMBL1060236	Binding constant for full-length AURKC	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903518	CHEMBL1060236	Binding constant for full-length AURKC	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	600.0	CHEMBL3935	Homo sapiens	Kd	nM	600.0
	2903519	CHEMBL1060236	Binding constant for full-length AURKC	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903520	CHEMBL1060236	Binding constant for full-length AURKC	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903521	CHEMBL1060236	Binding constant for full-length AURKC	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903522	CHEMBL1060236	Binding constant for full-length AURKC	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	750.0	CHEMBL3935	Homo sapiens	Kd	nM	750.0
	2903523	CHEMBL1060236	Binding constant for full-length AURKC	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903524	CHEMBL1060236	Binding constant for full-length AURKC	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	86.0	CHEMBL3935	Homo sapiens	Kd	nM	86.0
	2903525	CHEMBL1060236	Binding constant for full-length AURKC	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903526	CHEMBL1060236	Binding constant for full-length AURKC	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903527	CHEMBL1060236	Binding constant for full-length AURKC	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	1600.0	CHEMBL3935	Homo sapiens	Kd	nM	1600.0
	2903528	CHEMBL1060236	Binding constant for full-length AURKC	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	26.0	CHEMBL3935	Homo sapiens	Kd	nM	26.0
	2903529	CHEMBL1060236	Binding constant for full-length AURKC	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903530	CHEMBL1060236	Binding constant for full-length AURKC	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	170.0	CHEMBL3935	Homo sapiens	Kd	nM	170.0
	2903531	CHEMBL1060236	Binding constant for full-length AURKC	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903532	CHEMBL1060236	Binding constant for full-length AURKC	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903533	CHEMBL1060236	Binding constant for full-length AURKC	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903534	CHEMBL1060236	Binding constant for full-length AURKC	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903535	CHEMBL1060236	Binding constant for full-length AURKC	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903536	CHEMBL1060236	Binding constant for full-length AURKC	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	210.0	CHEMBL3935	Homo sapiens	Kd	nM	210.0
	2903537	CHEMBL1060236	Binding constant for full-length AURKC	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	23.0	CHEMBL3935	Homo sapiens	Kd	nM	23.0
	2903538	CHEMBL1060236	Binding constant for full-length AURKC	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	810.0	CHEMBL3935	Homo sapiens	Kd	nM	810.0
	2903539	CHEMBL1060236	Binding constant for full-length AURKC	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	220.0	CHEMBL3935	Homo sapiens	Kd	nM	220.0
	2903540	CHEMBL1060236	Binding constant for full-length AURKC	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	6.3	CHEMBL3935	Homo sapiens	Kd	nM	6.3
	2903541	CHEMBL1060236	Binding constant for full-length AURKC	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
	2903542	CHEMBL1060236	Binding constant for full-length AURKC	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1500.0	CHEMBL3935	Homo sapiens	Kd	nM	1500.0
	2921434	CHEMBL1059263	Inhibition of AURKC assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	86.0	CHEMBL3935	Homo sapiens	Activity	%	86.0
	2924825	CHEMBL1056879	Inhibition of AURORA C assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	99.0	CHEMBL3935	Homo sapiens	Activity	%	99.0
	2924826	CHEMBL1056879	Inhibition of AURORA C assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	85.0	CHEMBL3935	Homo sapiens	Activity	%	85.0
	2924827	CHEMBL1056879	Inhibition of AURORA C assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	104.0	CHEMBL3935	Homo sapiens	Activity	%	104.0
	2924828	CHEMBL1056879	Inhibition of AURORA C assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	79.0	CHEMBL3935	Homo sapiens	Activity	%	79.0
	2999020	CHEMBL1043723	Inhibition of Aurora C assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	110.0	CHEMBL3935	Homo sapiens	Activity	%	110.0
	2999810	CHEMBL1043723	Inhibition of Aurora C assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	35.0	CHEMBL3935	Homo sapiens	Activity	%	35.0
	3052531	CHEMBL1047782	Residual activity of Aurora-C at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	10.0	CHEMBL3935	Homo sapiens	Residual activity	%	10.0
	3052783	CHEMBL1047809	Residual activity of Aurora-C at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	2.0	CHEMBL3935	Homo sapiens	Residual activity	%	2.0
	3054092	CHEMBL1066610	Residual activity of Aurora-C at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	42.0	CHEMBL3935	Homo sapiens	Residual activity	%	42.0
	3055379	CHEMBL1047782	Residual activity of Aurora-C at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	11.0	CHEMBL3935	Homo sapiens	Residual activity	%	11.0
	3055631	CHEMBL1047809	Residual activity of Aurora-C at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	0.0	CHEMBL3935	Homo sapiens	Residual activity	%	0.0
	3056936	CHEMBL1066610	Residual activity of Aurora-C at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	42.0	CHEMBL3935	Homo sapiens	Residual activity	%	42.0
	3058256	CHEMBL1047782	Residual activity of Aurora-C at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	7.0	CHEMBL3935	Homo sapiens	Residual activity	%	7.0
	3058508	CHEMBL1047809	Residual activity of Aurora-C at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	1.0	CHEMBL3935	Homo sapiens	Residual activity	%	1.0
	3072854	CHEMBL1066610	Residual activity of Aurora-C at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	48.0	CHEMBL3935	Homo sapiens	Residual activity	%	48.0
	3203236	CHEMBL1101128	Inhibition of AURKC	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	23000.0	CHEMBL3935	Homo sapiens	Kd	uM	23.0
	3213876	CHEMBL1111292	Inhibition of auroraC at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	2.0	CHEMBL3935	Homo sapiens	INH	%	2.0
	3224741	CHEMBL1102602	Inhibition of Aurora C at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	3225010	CHEMBL1102602	Inhibition of Aurora C at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	3294177	CHEMBL1104797	Competitive inhibition of Aurora C ATP binding site	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	3294182	CHEMBL1104797	Competitive inhibition of Aurora C ATP binding site	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	IC50	nM	17.0	CHEMBL3935	Homo sapiens	IC50	nM	17.0
	3294185	CHEMBL1104797	Competitive inhibition of Aurora C ATP binding site	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Ki	nM	1.5	CHEMBL3935	Homo sapiens	Ki	nM	1.5
	3294231	CHEMBL1105648	Competitive inhibition of human Aurora C ATP binding site	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Ki	nM	1.5	CHEMBL3935	Homo sapiens	Ki	nM	1.5
	3294236	CHEMBL1104807	Inhibition of human Aurora C assessed as dissociation half life by rapid dilution method	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Activity	min	270.0	CHEMBL3935	Homo sapiens	Activity	min	270.0
	3294242	CHEMBL1104797	Competitive inhibition of Aurora C ATP binding site	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	6.5	CHEMBL3935	Homo sapiens	IC50	nM	6.5
	3302027	CHEMBL1118618	Inhibition of human recombinant Aurora C expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(N5CCN(C)CC5)nc34)CC2)no1		CHEMBL1086579	=	IC50	nM	19.0	CHEMBL3935	Homo sapiens	IC50	uM	0.019
	3331834	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	3333249	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	3334654	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	3336074	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	3337457	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	3337705	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	3339037	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	=	Inhibition	%	79.5	CHEMBL3935	Homo sapiens	INH	%	79.5
	3339293	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	96.9	CHEMBL3935	Homo sapiens	INH	%	96.9
	3340602	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	92.0	CHEMBL3935	Homo sapiens	INH	%	92.0
	3342018	CHEMBL1168793	Inhibition of AURKC at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	=	Inhibition	%	89.0	CHEMBL3935	Homo sapiens	INH	%	89.0
	3344661	CHEMBL1167925	Inhibition of Aurora C assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	92.0	CHEMBL3935	Homo sapiens	Activity	%	92.0
	3344662	CHEMBL1167926	Inhibition of Aurora C assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	83.0	CHEMBL3935	Homo sapiens	Activity	%	83.0
	3345494	CHEMBL1166284	Inhibition of GST-tagged human recombinant Aurora C kinase at 20 uM	B	COc1cc(C(=O)OCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O		CHEMBL1164563	>	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	3358461	CHEMBL1174075	Inhibition of AURKC at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	13.0	CHEMBL3935	Homo sapiens	INH	%	13.0
	3358903	CHEMBL1174075	Inhibition of AURKC at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	11.0	CHEMBL3935	Homo sapiens	INH	%	11.0
	3370116	CHEMBL1176693	Inhibition of Aurora C at 10 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	Inhibition	%	84.2	CHEMBL3935	Homo sapiens	INH	%	84.2
	3443342	CHEMBL1244375	Inhibition of AURKC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	3.0	CHEMBL3935	Homo sapiens	INH	%	3.0
	3443559	CHEMBL1244375	Inhibition of AURKC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	8.0	CHEMBL3935	Homo sapiens	INH	%	8.0
	3444714	CHEMBL1244375	Inhibition of AURKC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	1.0	CHEMBL3935	Homo sapiens	INH	%	1.0
	3445035	CHEMBL1244731	Binding affinity to AURKC	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4.1	CHEMBL3935	Homo sapiens	Kd	nM	4.1
	3445338	CHEMBL1244375	Inhibition of AURKC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	2.0	CHEMBL3935	Homo sapiens	INH	%	2.0
	3445555	CHEMBL1244375	Inhibition of AURKC at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	10.0	CHEMBL3935	Homo sapiens	INH	%	10.0
	3448834	CHEMBL1244731	Binding affinity to AURKC	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	1600.0	CHEMBL3935	Homo sapiens	Kd	nM	1600.0
	3448884	CHEMBL1244731	Binding affinity to AURKC	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	170.0	CHEMBL3935	Homo sapiens	Kd	nM	170.0
	3449106	CHEMBL1244731	Binding affinity to AURKC	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	210.0	CHEMBL3935	Homo sapiens	Kd	nM	210.0
	3449107	CHEMBL1244731	Binding affinity to AURKC	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	220.0	CHEMBL3935	Homo sapiens	Kd	nM	220.0
	3449108	CHEMBL1244731	Binding affinity to AURKC	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	800.0	CHEMBL3935	Homo sapiens	Kd	nM	800.0
	3449567	CHEMBL1244731	Binding affinity to AURKC	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	uM	10.0
Not Active	3499117	CHEMBL1259861	Inhibition of aurora C at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
	3504227	CHEMBL1260158	Inhibition of aurora C	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	=	IC50	nM	62.0	CHEMBL3935	Homo sapiens	IC50	uM	0.062
	3505266	CHEMBL1261373	Inhibition of human aurora C	B	Clc1cnc2c(Nc3ccc(N4CCOCC4)cc3)nc(-c3cccnc3)cn12		CHEMBL1231066	=	IC50	nM	1950.0	CHEMBL3935	Homo sapiens	IC50	uM	1.95
	3590781	CHEMBL1292144	Inhibition of human Aurora C	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Outside typical range	CHEMBL1290072	>	Ki	nM	1000000.0	CHEMBL3935	Homo sapiens	Ki	uM	1000.0
	5123788	CHEMBL1649028	Inhibition of AURKC at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	99.0	CHEMBL3935	Homo sapiens	INH	%	99.0
	6204400	CHEMBL1781287	Inhibition of aurora C	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	6264911	CHEMBL1799794	Inhibition of AURKC at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL3935	Homo sapiens	INH	%	65.0
	6265635	CHEMBL1799794	Inhibition of AURKC at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL3935	Homo sapiens	INH	%	65.0
	6340930	CHEMBL1826954	Activity of AURKC kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	92.0	CHEMBL3935	Homo sapiens	Activity	%	92.0
Not Determined	6342727	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cc(F)cc(F)c5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822660		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342732	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822659		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342744	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822658		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342749	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cccc(F)c5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822657		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342754	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccccc5F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822656		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342759	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(=NO)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822655		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342764	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822654		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342769	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OCC5CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822653		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342774	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822652		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342779	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	COCCO[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O		CHEMBL1822651		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342784	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	CCC(C)(C)O[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O		CHEMBL1822650		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342789	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C(F)(F)F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822649		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342794	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822648		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342803	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822647		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342808	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](N)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822646		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342813	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822645		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342818	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](SC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822644		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342823	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822643		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342828	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822642		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342833	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H]5C[C@H]5[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822641		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342838	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822640		Kd			CHEMBL3935	Homo sapiens	Kd		
Not Determined	6342843	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822639		Kd			CHEMBL3935	Homo sapiens	Kd		
	6342848	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(F)(F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822638	=	Kd	nM	2.0	CHEMBL3935	Homo sapiens	Kd	nM	2.0
	6342857	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822637	=	Kd	nM	2.0	CHEMBL3935	Homo sapiens	Kd	nM	2.0
	6342862	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822495	=	Kd	nM	1.0	CHEMBL3935	Homo sapiens	Kd	nM	1.0
	6342867	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN(C)C)cc3)nn3cccc23)n[nH]1		CHEMBL1822494	=	Kd	nM	5.0	CHEMBL3935	Homo sapiens	Kd	nM	5.0
	6342872	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCOCC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822493	=	Kd	nM	17.0	CHEMBL3935	Homo sapiens	Kd	nM	17.0
	6342877	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CCCC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822492	=	Kd	nM	14.0	CHEMBL3935	Homo sapiens	Kd	nM	14.0
	6342882	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822491	=	Kd	nM	6.0	CHEMBL3935	Homo sapiens	Kd	nM	6.0
	6342891	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822485	=	Kd	nM	4.0	CHEMBL3935	Homo sapiens	Kd	nM	4.0
Not Determined	6342895	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)[C@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822661		Kd			CHEMBL3935	Homo sapiens	Kd		
	6342900	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CCN4CCCCC4)cc23)n[nH]1		CHEMBL1822486	=	Kd	nM	10.0	CHEMBL3935	Homo sapiens	Kd	nM	10.0
	6342905	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCOCC4)cc23)n[nH]1		CHEMBL1822487	=	Kd	nM	3.0	CHEMBL3935	Homo sapiens	Kd	nM	3.0
	6342910	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCCC4)cc23)n[nH]1		CHEMBL1822488	=	Kd	nM	13.0	CHEMBL3935	Homo sapiens	Kd	nM	13.0
	6342915	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCC[C@@H]4CO)cc23)n[nH]1		CHEMBL1822489	=	Kd	nM	80.0	CHEMBL3935	Homo sapiens	Kd	nM	80.0
	6342920	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)C(=O)N4CCN(C)CC4)cc23)n[nH]1		CHEMBL1822490	=	Kd	nM	5.0	CHEMBL3935	Homo sapiens	Kd	nM	5.0
	6342929	CHEMBL1827220	Binding affinity to Aurora C kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	6.0	CHEMBL3935	Homo sapiens	Kd	nM	6.0
	6385623	CHEMBL1837984	Inhibition of human AurC in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL3935	Homo sapiens	INH	%	35.0
	6385624	CHEMBL1837984	Inhibition of human AurC in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL3935	Homo sapiens	INH	%	35.0
	6385625	CHEMBL1837984	Inhibition of human AurC in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL3935	Homo sapiens	INH	%	35.0
	6385626	CHEMBL1837984	Inhibition of human AurC in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL3935	Homo sapiens	INH	%	35.0
	6385627	CHEMBL1837984	Inhibition of human AurC in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL3935	Homo sapiens	INH	%	35.0
	7567163	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	2100.0	CHEMBL3935	Homo sapiens	Kd	nM	2100.0
	7567622	CHEMBL1908466	Binding constant for AURKC kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7568093	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7568561	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	300.0	CHEMBL3935	Homo sapiens	Kd	nM	300.0
	7568993	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	220.0	CHEMBL3935	Homo sapiens	Kd	nM	220.0
	7569136	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7569596	CHEMBL1908466	Binding constant for AURKC kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	4300.0	CHEMBL3935	Homo sapiens	Kd	nM	4300.0
	7570068	CHEMBL1908466	Binding constant for AURKC kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	8700.0	CHEMBL3935	Homo sapiens	Kd	nM	8700.0
	7570531	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7571112	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7571569	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7572045	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	3000.0	CHEMBL3935	Homo sapiens	Kd	nM	3000.0
	7572482	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	33.0	CHEMBL3935	Homo sapiens	Kd	nM	33.0
	7573093	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	190.0	CHEMBL3935	Homo sapiens	Kd	nM	190.0
	7573550	CHEMBL1908466	Binding constant for AURKC kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	600.0	CHEMBL3935	Homo sapiens	Kd	nM	600.0
	7574053	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	170.0	CHEMBL3935	Homo sapiens	Kd	nM	170.0
	7574461	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7575071	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7575561	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	150.0	CHEMBL3935	Homo sapiens	Kd	nM	150.0
	7576026	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	2500.0	CHEMBL3935	Homo sapiens	Kd	nM	2500.0
	7576434	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	350.0	CHEMBL3935	Homo sapiens	Kd	nM	350.0
	7577045	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7577062	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	12.0	CHEMBL3935	Homo sapiens	Kd	nM	12.0
	7577540	CHEMBL1908466	Binding constant for AURKC kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	59.0	CHEMBL3935	Homo sapiens	Kd	nM	59.0
	7578010	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7578415	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1500.0	CHEMBL3935	Homo sapiens	Kd	nM	1500.0
	7578611	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	8400.0	CHEMBL3935	Homo sapiens	Kd	nM	8400.0
	7579435	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7579909	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7580378	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7580781	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	6.3	CHEMBL3935	Homo sapiens	Kd	nM	6.3
	7580969	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7581354	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7581799	CHEMBL1908466	Binding constant for AURKC kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7582270	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7582734	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	41.0	CHEMBL3935	Homo sapiens	Kd	nM	41.0
	7583134	CHEMBL1908466	Binding constant for AURKC kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7583315	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	71.0	CHEMBL3935	Homo sapiens	Kd	nM	71.0
	7583712	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	5000.0	CHEMBL3935	Homo sapiens	Kd	nM	5000.0
	7584157	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7584628	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7585090	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7585645	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7586053	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7586499	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7586970	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7587606	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1.3	CHEMBL3935	Homo sapiens	Kd	nM	1.3
	7588025	CHEMBL1908466	Binding constant for AURKC kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4.1	CHEMBL3935	Homo sapiens	Kd	nM	4.1
	7588478	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7588958	CHEMBL1908466	Binding constant for AURKC kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7589571	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	1900.0	CHEMBL3935	Homo sapiens	Kd	nM	1900.0
	7589995	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1100.0	CHEMBL3935	Homo sapiens	Kd	nM	1100.0
	7590462	CHEMBL1908466	Binding constant for AURKC kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7590494	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	1600.0	CHEMBL3935	Homo sapiens	Kd	nM	1600.0
	7590945	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7591544	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	740.0	CHEMBL3935	Homo sapiens	Kd	nM	740.0
	7591966	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7592469	CHEMBL1908466	Binding constant for AURKC kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	26.0	CHEMBL3935	Homo sapiens	Kd	nM	26.0
	7592922	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7593511	CHEMBL1908466	Binding constant for AURKC kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7593976	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7594449	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7594901	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	210.0	CHEMBL3935	Homo sapiens	Kd	nM	210.0
	7595481	CHEMBL1908466	Binding constant for AURKC kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2800.0	CHEMBL3935	Homo sapiens	Kd	nM	2800.0
	7595955	CHEMBL1908466	Binding constant for AURKC kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7596426	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	750.0	CHEMBL3935	Homo sapiens	Kd	nM	750.0
	7596873	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	23.0	CHEMBL3935	Homo sapiens	Kd	nM	23.0
	7597009	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	4.4	CHEMBL3935	Homo sapiens	Kd	nM	4.4
	7597462	CHEMBL1908466	Binding constant for AURKC kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Kd	nM	1800.0	CHEMBL3935	Homo sapiens	Kd	nM	1800.0
	7597935	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3935	Homo sapiens	Kd	nM	10000.0
	7598405	CHEMBL1908466	Binding constant for AURKC kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	5100.0	CHEMBL3935	Homo sapiens	Kd	nM	5100.0
	7598847	CHEMBL1908466	Binding constant for AURKC kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	810.0	CHEMBL3935	Homo sapiens	Kd	nM	810.0
	7996678	CHEMBL1944009	Inhibition of AURKC at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	97.0	CHEMBL3935	Homo sapiens	INH	%	97.0
	7996741	CHEMBL1944009	Inhibition of AURKC at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	97.0	CHEMBL3935	Homo sapiens	INH	%	97.0
	8047079	CHEMBL1958814	Inhibition of AURKC at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	8061333	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.89	CHEMBL3935	Homo sapiens	Inhibition	%	1.89
	8061510	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	10.62	CHEMBL3935	Homo sapiens	Inhibition	%	10.62
	8061841	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-2.98	CHEMBL3935	Homo sapiens	Inhibition	%	-2.98
	8062032	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.21	CHEMBL3935	Homo sapiens	Inhibition	%	5.21
	8062372	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.42	CHEMBL3935	Homo sapiens	Inhibition	%	1.42
	8062534	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-7.86	CHEMBL3935	Homo sapiens	Inhibition	%	-7.86
	8062856	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	6.04	CHEMBL3935	Homo sapiens	Inhibition	%	6.04
	8063212	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	5.03	CHEMBL3935	Homo sapiens	Inhibition	%	5.03
	8063379	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.61	CHEMBL3935	Homo sapiens	Inhibition	%	0.61
	8063711	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.68	CHEMBL3935	Homo sapiens	Inhibition	%	1.68
	8063893	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	62.65	CHEMBL3935	Homo sapiens	Inhibition	%	62.65
	8064232	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.49	CHEMBL3935	Homo sapiens	Inhibition	%	4.49
	8064442	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.89	CHEMBL3935	Homo sapiens	Inhibition	%	0.89
	8064804	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	10.24	CHEMBL3935	Homo sapiens	Inhibition	%	10.24
	8064970	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-3.91	CHEMBL3935	Homo sapiens	Inhibition	%	-3.91
	8065194	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-5.01	CHEMBL3935	Homo sapiens	Inhibition	%	-5.01
	8065310	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-2.72	CHEMBL3935	Homo sapiens	Inhibition	%	-2.72
	8065485	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.81	CHEMBL3935	Homo sapiens	Inhibition	%	1.81
	8065709	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	19.86	CHEMBL3935	Homo sapiens	Inhibition	%	19.86
	8065824	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.17	CHEMBL3935	Homo sapiens	Inhibition	%	1.17
	8066034	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	14.02	CHEMBL3935	Homo sapiens	Inhibition	%	14.02
	8066258	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.67	CHEMBL3935	Homo sapiens	Inhibition	%	0.67
	8066394	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	82.23	CHEMBL3935	Homo sapiens	Inhibition	%	82.23
	8066784	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	8.55	CHEMBL3935	Homo sapiens	Inhibition	%	8.55
	8066908	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	11.45	CHEMBL3935	Homo sapiens	Inhibition	%	11.45
	8067132	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	42.54	CHEMBL3935	Homo sapiens	Inhibition	%	42.54
	8067307	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.87	CHEMBL3935	Homo sapiens	Inhibition	%	0.87
	8067428	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	43.68	CHEMBL3935	Homo sapiens	Inhibition	%	43.68
	8067652	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.61	CHEMBL3935	Homo sapiens	Inhibition	%	0.61
	8067862	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	5.21	CHEMBL3935	Homo sapiens	Inhibition	%	5.21
	8067997	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%		CHEMBL3935	Homo sapiens	Inhibition	%	
	8068221	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	94.42	CHEMBL3935	Homo sapiens	Inhibition	%	94.42
	8068385	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.44	CHEMBL3935	Homo sapiens	Inhibition	%	1.44
	8068734	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.83	CHEMBL3935	Homo sapiens	Inhibition	%	0.83
	8068908	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	14.07	CHEMBL3935	Homo sapiens	Inhibition	%	14.07
	8069257	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.01	CHEMBL3935	Homo sapiens	Inhibition	%	2.01
	8069552	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	13.06	CHEMBL3935	Homo sapiens	Inhibition	%	13.06
	8069713	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.62	CHEMBL3935	Homo sapiens	Inhibition	%	5.62
	8070063	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-4.93	CHEMBL3935	Homo sapiens	Inhibition	%	-4.93
	8070235	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.18	CHEMBL3935	Homo sapiens	Inhibition	%	2.18
	8070584	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.22	CHEMBL3935	Homo sapiens	Inhibition	%	1.22
	8070882	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	88.27	CHEMBL3935	Homo sapiens	Inhibition	%	88.27
	8071039	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.52	CHEMBL3935	Homo sapiens	Inhibition	%	2.52
	8071263	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-3.99	CHEMBL3935	Homo sapiens	Inhibition	%	-3.99
	8071389	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.3	CHEMBL3935	Homo sapiens	Inhibition	%	0.3
	8071562	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	15.43	CHEMBL3935	Homo sapiens	Inhibition	%	15.43
	8071786	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.71	CHEMBL3935	Homo sapiens	Inhibition	%	2.71
	8071911	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.07	CHEMBL3935	Homo sapiens	Inhibition	%	-0.07
	8072225	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.03	CHEMBL3935	Homo sapiens	Inhibition	%	0.03
	8072606	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	28.93	CHEMBL3935	Homo sapiens	Inhibition	%	28.93
	8072731	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-2.95	CHEMBL3935	Homo sapiens	Inhibition	%	-2.95
	8073122	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	29.38	CHEMBL3935	Homo sapiens	Inhibition	%	29.38
	8073247	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	9.05	CHEMBL3935	Homo sapiens	Inhibition	%	9.05
	8073471	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	50.41	CHEMBL3935	Homo sapiens	Inhibition	%	50.41
	8073590	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.16	CHEMBL3935	Homo sapiens	Inhibition	%	1.16
	8073823	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	4.29	CHEMBL3935	Homo sapiens	Inhibition	%	4.29
	8074199	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	42.58	CHEMBL3935	Homo sapiens	Inhibition	%	42.58
	8074329	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	3.22	CHEMBL3935	Homo sapiens	Inhibition	%	3.22
	8074553	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	46.18	CHEMBL3935	Homo sapiens	Inhibition	%	46.18
	8074710	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.43	CHEMBL3935	Homo sapiens	Inhibition	%	-0.43
	8075061	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.27	CHEMBL3935	Homo sapiens	Inhibition	%	0.27
	8075172	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	23.59	CHEMBL3935	Homo sapiens	Inhibition	%	23.59
	8075396	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.04	CHEMBL3935	Homo sapiens	Inhibition	%	-0.04
	8075409	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.15	CHEMBL3935	Homo sapiens	Inhibition	%	0.15
	8075633	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	23.3	CHEMBL3935	Homo sapiens	Inhibition	%	23.3
	8075774	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.84	CHEMBL3935	Homo sapiens	Inhibition	%	5.84
	8076140	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-1.97	CHEMBL3935	Homo sapiens	Inhibition	%	-1.97
	8076288	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	8.16	CHEMBL3935	Homo sapiens	Inhibition	%	8.16
	8076646	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.31	CHEMBL3935	Homo sapiens	Inhibition	%	-0.31
	8076972	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	10.09	CHEMBL3935	Homo sapiens	Inhibition	%	10.09
	8077219	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.63	CHEMBL3935	Homo sapiens	Inhibition	%	-0.63
	8077347	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-0.75	CHEMBL3935	Homo sapiens	Inhibition	%	-0.75
	8077722	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.3	CHEMBL3935	Homo sapiens	Inhibition	%	-0.3
	8077865	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.23	CHEMBL3935	Homo sapiens	Inhibition	%	1.23
	8078089	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	8.14	CHEMBL3935	Homo sapiens	Inhibition	%	8.14
	8078228	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.76	CHEMBL3935	Homo sapiens	Inhibition	%	-0.76
	8078554	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.7	CHEMBL3935	Homo sapiens	Inhibition	%	-0.7
	8078804	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.38	CHEMBL3935	Homo sapiens	Inhibition	%	1.38
	8078920	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.31	CHEMBL3935	Homo sapiens	Inhibition	%	1.31
	8079144	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-2.81	CHEMBL3935	Homo sapiens	Inhibition	%	-2.81
	8079302	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.38	CHEMBL3935	Homo sapiens	Inhibition	%	-1.38
	8079668	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.94	CHEMBL3935	Homo sapiens	Inhibition	%	0.94
	8079807	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	22.42	CHEMBL3935	Homo sapiens	Inhibition	%	22.42
	8080136	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	10.05	CHEMBL3935	Homo sapiens	Inhibition	%	10.05
	8080388	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.05	CHEMBL3935	Homo sapiens	Inhibition	%	4.05
	8080727	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.84	CHEMBL3935	Homo sapiens	Inhibition	%	1.84
	8080891	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-2.42	CHEMBL3935	Homo sapiens	Inhibition	%	-2.42
	8081250	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	7.34	CHEMBL3935	Homo sapiens	Inhibition	%	7.34
	8081394	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.37	CHEMBL3935	Homo sapiens	Inhibition	%	0.37
	8081618	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	-4.81	CHEMBL3935	Homo sapiens	Inhibition	%	-4.81
	8081721	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.02	CHEMBL3935	Homo sapiens	Inhibition	%	1.02
	8081973	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	82.92	CHEMBL3935	Homo sapiens	Inhibition	%	82.92
	8082310	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	10.48	CHEMBL3935	Homo sapiens	Inhibition	%	10.48
	8082483	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-7.14	CHEMBL3935	Homo sapiens	Inhibition	%	-7.14
	8082707	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-5.53	CHEMBL3935	Homo sapiens	Inhibition	%	-5.53
	8082830	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.47	CHEMBL3935	Homo sapiens	Inhibition	%	0.47
	8083210	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.31	CHEMBL3935	Homo sapiens	Inhibition	%	3.31
	8083309	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	13.14	CHEMBL3935	Homo sapiens	Inhibition	%	13.14
	8083533	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.43	CHEMBL3935	Homo sapiens	Inhibition	%	1.43
	8083563	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.66	CHEMBL3935	Homo sapiens	Inhibition	%	-0.66
	8083787	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	5.22	CHEMBL3935	Homo sapiens	Inhibition	%	5.22
	8083897	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.63	CHEMBL3935	Homo sapiens	Inhibition	%	1.63
	8084306	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	15.78	CHEMBL3935	Homo sapiens	Inhibition	%	15.78
	8084424	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	7.37	CHEMBL3935	Homo sapiens	Inhibition	%	7.37
	8084648	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.76	CHEMBL3935	Homo sapiens	Inhibition	%	2.76
	8084809	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	23.18	CHEMBL3935	Homo sapiens	Inhibition	%	23.18
	8085131	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	15.64	CHEMBL3935	Homo sapiens	Inhibition	%	15.64
	8085387	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.25	CHEMBL3935	Homo sapiens	Inhibition	%	1.25
	8085495	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.25	CHEMBL3935	Homo sapiens	Inhibition	%	1.25
	8085719	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.71	CHEMBL3935	Homo sapiens	Inhibition	%	0.71
	8085908	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	91.94	CHEMBL3935	Homo sapiens	Inhibition	%	91.94
	8086247	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	27.64	CHEMBL3935	Homo sapiens	Inhibition	%	27.64
	8086409	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.83	CHEMBL3935	Homo sapiens	Inhibition	%	-1.83
	8086732	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.9	CHEMBL3935	Homo sapiens	Inhibition	%	0.9
	8086943	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-4.44	CHEMBL3935	Homo sapiens	Inhibition	%	-4.44
	8087325	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-1.01	CHEMBL3935	Homo sapiens	Inhibition	%	-1.01
	8087439	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	28.2	CHEMBL3935	Homo sapiens	Inhibition	%	28.2
	8087663	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.63	CHEMBL3935	Homo sapiens	Inhibition	%	3.63
	8087801	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	26.11	CHEMBL3935	Homo sapiens	Inhibition	%	26.11
	8088167	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.12	CHEMBL3935	Homo sapiens	Inhibition	%	1.12
	8088315	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.13	CHEMBL3935	Homo sapiens	Inhibition	%	0.13
	8088667	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	8.0	CHEMBL3935	Homo sapiens	Inhibition	%	8.0
	8088984	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	11.2	CHEMBL3935	Homo sapiens	Inhibition	%	11.2
	8089112	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	2.93	CHEMBL3935	Homo sapiens	Inhibition	%	2.93
	8089484	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	5.14	CHEMBL3935	Homo sapiens	Inhibition	%	5.14
	8089604	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-2.58	CHEMBL3935	Homo sapiens	Inhibition	%	-2.58
	8089828	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.38	CHEMBL3935	Homo sapiens	Inhibition	%	1.38
	8090008	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.73	CHEMBL3935	Homo sapiens	Inhibition	%	0.73
	8090173	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.27	CHEMBL3935	Homo sapiens	Inhibition	%	-0.27
	8090397	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.25	CHEMBL3935	Homo sapiens	Inhibition	%	3.25
	8090564	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.43	CHEMBL3935	Homo sapiens	Inhibition	%	1.43
	8090703	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	12.51	CHEMBL3935	Homo sapiens	Inhibition	%	12.51
	8090927	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	30.73	CHEMBL3935	Homo sapiens	Inhibition	%	30.73
	8091132	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.17	CHEMBL3935	Homo sapiens	Inhibition	%	2.17
	8091269	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.68	CHEMBL3935	Homo sapiens	Inhibition	%	0.68
	8091493	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.85	CHEMBL3935	Homo sapiens	Inhibition	%	1.85
	8091648	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.82	CHEMBL3935	Homo sapiens	Inhibition	%	3.82
	8091988	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	12.5	CHEMBL3935	Homo sapiens	Inhibition	%	12.5
	8092125	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-4.42	CHEMBL3935	Homo sapiens	Inhibition	%	-4.42
	8092500	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.65	CHEMBL3935	Homo sapiens	Inhibition	%	3.65
	8092648	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	4.66	CHEMBL3935	Homo sapiens	Inhibition	%	4.66
	8092872	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.7	CHEMBL3935	Homo sapiens	Inhibition	%	1.7
	8093001	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	49.31	CHEMBL3935	Homo sapiens	Inhibition	%	49.31
	8093313	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.36	CHEMBL3935	Homo sapiens	Inhibition	%	0.36
	8093453	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-1.8	CHEMBL3935	Homo sapiens	Inhibition	%	-1.8
	8093677	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	4.3	CHEMBL3935	Homo sapiens	Inhibition	%	4.3
	8093816	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	65.62	CHEMBL3935	Homo sapiens	Inhibition	%	65.62
	8094160	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-2.79	CHEMBL3935	Homo sapiens	Inhibition	%	-2.79
	8094340	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.32	CHEMBL3935	Homo sapiens	Inhibition	%	-0.32
	8094739	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.8	CHEMBL3935	Homo sapiens	Inhibition	%	0.8
	8094895	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	12.1	CHEMBL3935	Homo sapiens	Inhibition	%	12.1
	8095259	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	96.53	CHEMBL3935	Homo sapiens	Inhibition	%	96.53
	8095462	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	7.65	CHEMBL3935	Homo sapiens	Inhibition	%	7.65
	8095827	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	13.66	CHEMBL3935	Homo sapiens	Inhibition	%	13.66
	8095975	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.9	CHEMBL3935	Homo sapiens	Inhibition	%	1.9
	8096316	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.56	CHEMBL3935	Homo sapiens	Inhibition	%	0.56
	8096455	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.24	CHEMBL3935	Homo sapiens	Inhibition	%	-1.24
	8096679	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.09	CHEMBL3935	Homo sapiens	Inhibition	%	-0.09
	8096835	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.71	CHEMBL3935	Homo sapiens	Inhibition	%	8.71
	8097206	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	7.89	CHEMBL3935	Homo sapiens	Inhibition	%	7.89
	8097293	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.77	CHEMBL3935	Homo sapiens	Inhibition	%	1.77
	8097513	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.19	CHEMBL3935	Homo sapiens	Inhibition	%	2.19
	8097887	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.02	CHEMBL3935	Homo sapiens	Inhibition	%	-0.02
	8098020	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.03	CHEMBL3935	Homo sapiens	Inhibition	%	0.03
	8098364	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.58	CHEMBL3935	Homo sapiens	Inhibition	%	1.58
	8098544	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	7.33	CHEMBL3935	Homo sapiens	Inhibition	%	7.33
	8098768	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.82	CHEMBL3935	Homo sapiens	Inhibition	%	0.82
	8098953	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.67	CHEMBL3935	Homo sapiens	Inhibition	%	2.67
	8099097	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.46	CHEMBL3935	Homo sapiens	Inhibition	%	1.46
	8099463	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.0	CHEMBL3935	Homo sapiens	Inhibition	%	3.0
	8099657	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.81	CHEMBL3935	Homo sapiens	Inhibition	%	0.81
	8100028	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.92	CHEMBL3935	Homo sapiens	Inhibition	%	1.92
	8100174	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	23.68	CHEMBL3935	Homo sapiens	Inhibition	%	23.68
	8100398	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-3.12	CHEMBL3935	Homo sapiens	Inhibition	%	-3.12
	8100514	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.96	CHEMBL3935	Homo sapiens	Inhibition	%	3.96
	8100878	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.6	CHEMBL3935	Homo sapiens	Inhibition	%	1.6
	8101038	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.6	CHEMBL3935	Homo sapiens	Inhibition	%	1.6
	8101404	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	8.67	CHEMBL3935	Homo sapiens	Inhibition	%	8.67
	8101589	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-3.77	CHEMBL3935	Homo sapiens	Inhibition	%	-3.77
	8101842	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	13.16	CHEMBL3935	Homo sapiens	Inhibition	%	13.16
	8102221	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	39.2	CHEMBL3935	Homo sapiens	Inhibition	%	39.2
	8102352	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	37.7	CHEMBL3935	Homo sapiens	Inhibition	%	37.7
	8102576	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.12	CHEMBL3935	Homo sapiens	Inhibition	%	2.12
	8102696	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	3.73	CHEMBL3935	Homo sapiens	Inhibition	%	3.73
	8103098	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	6.4	CHEMBL3935	Homo sapiens	Inhibition	%	6.4
	8103294	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.89	CHEMBL3935	Homo sapiens	Inhibition	%	1.89
	8103432	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	8.58	CHEMBL3935	Homo sapiens	Inhibition	%	8.58
	8103656	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	25.61	CHEMBL3935	Homo sapiens	Inhibition	%	25.61
	8103806	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	11.89	CHEMBL3935	Homo sapiens	Inhibition	%	11.89
	8103991	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	5.38	CHEMBL3935	Homo sapiens	Inhibition	%	5.38
	8104215	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	16.58	CHEMBL3935	Homo sapiens	Inhibition	%	16.58
	8104363	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.66	CHEMBL3935	Homo sapiens	Inhibition	%	4.66
	8104733	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	11.52	CHEMBL3935	Homo sapiens	Inhibition	%	11.52
	8104847	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.14	CHEMBL3935	Homo sapiens	Inhibition	%	0.14
	8105071	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.86	CHEMBL3935	Homo sapiens	Inhibition	%	3.86
	8105211	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.39	CHEMBL3935	Homo sapiens	Inhibition	%	-0.39
	8105377	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.22	CHEMBL3935	Homo sapiens	Inhibition	%	5.22
	8105601	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-3.34	CHEMBL3935	Homo sapiens	Inhibition	%	-3.34
	8105739	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	71.77	CHEMBL3935	Homo sapiens	Inhibition	%	71.77
	8106019	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.09	CHEMBL3935	Homo sapiens	Inhibition	%	2.09
	8106184	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	90.25	CHEMBL3935	Homo sapiens	Inhibition	%	90.25
	8106408	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-1.31	CHEMBL3935	Homo sapiens	Inhibition	%	-1.31
	8106564	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	100.43	CHEMBL3935	Homo sapiens	Inhibition	%	100.43
	8106917	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-4.34	CHEMBL3935	Homo sapiens	Inhibition	%	-4.34
	8107038	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.13	CHEMBL3935	Homo sapiens	Inhibition	%	0.13
	8107262	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	19.5	CHEMBL3935	Homo sapiens	Inhibition	%	19.5
	8107434	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.36	CHEMBL3935	Homo sapiens	Inhibition	%	1.36
	8107635	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.08	CHEMBL3935	Homo sapiens	Inhibition	%	2.08
	8107994	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	85.2	CHEMBL3935	Homo sapiens	Inhibition	%	85.2
	8108152	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.07	CHEMBL3935	Homo sapiens	Inhibition	%	5.07
	8108551	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	35.26	CHEMBL3935	Homo sapiens	Inhibition	%	35.26
	8108698	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	-0.3	CHEMBL3935	Homo sapiens	Inhibition	%	-0.3
	8109064	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.03	CHEMBL3935	Homo sapiens	Inhibition	%	-0.03
	8109402	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.24	CHEMBL3935	Homo sapiens	Inhibition	%	0.24
	8109532	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-1.12	CHEMBL3935	Homo sapiens	Inhibition	%	-1.12
	8109927	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.29	CHEMBL3935	Homo sapiens	Inhibition	%	-1.29
	8110059	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.27	CHEMBL3935	Homo sapiens	Inhibition	%	3.27
	8110338	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	15.29	CHEMBL3935	Homo sapiens	Inhibition	%	15.29
	8110728	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.03	CHEMBL3935	Homo sapiens	Inhibition	%	-0.03
	8110886	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	3.54	CHEMBL3935	Homo sapiens	Inhibition	%	3.54
	8111233	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	10.32	CHEMBL3935	Homo sapiens	Inhibition	%	10.32
	8111584	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.23	CHEMBL3935	Homo sapiens	Inhibition	%	1.23
	8111750	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.02	CHEMBL3935	Homo sapiens	Inhibition	%	4.02
	8111955	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.68	CHEMBL3935	Homo sapiens	Inhibition	%	0.68
	8112179	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	11.21	CHEMBL3935	Homo sapiens	Inhibition	%	11.21
	8112316	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.6	CHEMBL3935	Homo sapiens	Inhibition	%	0.6
	8112484	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	20.8	CHEMBL3935	Homo sapiens	Inhibition	%	20.8
	8112708	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	4.24	CHEMBL3935	Homo sapiens	Inhibition	%	4.24
	8112880	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.25	CHEMBL3935	Homo sapiens	Inhibition	%	3.25
	8113032	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.0	CHEMBL3935	Homo sapiens	Inhibition	%	3.0
	8113256	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-0.74	CHEMBL3935	Homo sapiens	Inhibition	%	-0.74
	8113392	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.99	CHEMBL3935	Homo sapiens	Inhibition	%	5.99
	8113740	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.19	CHEMBL3935	Homo sapiens	Inhibition	%	3.19
	8113856	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-4.59	CHEMBL3935	Homo sapiens	Inhibition	%	-4.59
	8114080	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.84	CHEMBL3935	Homo sapiens	Inhibition	%	-1.84
	8114256	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.93	CHEMBL3935	Homo sapiens	Inhibition	%	1.93
	8114388	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	29.63	CHEMBL3935	Homo sapiens	Inhibition	%	29.63
	8114612	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.96	CHEMBL3935	Homo sapiens	Inhibition	%	5.96
	8114664	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.71	CHEMBL3935	Homo sapiens	Inhibition	%	2.71
	8114888	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	13.97	CHEMBL3935	Homo sapiens	Inhibition	%	13.97
	8115054	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	13.37	CHEMBL3935	Homo sapiens	Inhibition	%	13.37
	8115219	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-8.09	CHEMBL3935	Homo sapiens	Inhibition	%	-8.09
	8115443	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.46	CHEMBL3935	Homo sapiens	Inhibition	%	3.46
	8115563	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	37.45	CHEMBL3935	Homo sapiens	Inhibition	%	37.45
	8115920	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.45	CHEMBL3935	Homo sapiens	Inhibition	%	1.45
	8116079	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	3.09	CHEMBL3935	Homo sapiens	Inhibition	%	3.09
	8116506	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.48	CHEMBL3935	Homo sapiens	Inhibition	%	1.48
	8116640	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	4.15	CHEMBL3935	Homo sapiens	Inhibition	%	4.15
	8117036	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	24.59	CHEMBL3935	Homo sapiens	Inhibition	%	24.59
	8117207	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	9.46	CHEMBL3935	Homo sapiens	Inhibition	%	9.46
	8117589	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.76	CHEMBL3935	Homo sapiens	Inhibition	%	3.76
	8117719	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.18	CHEMBL3935	Homo sapiens	Inhibition	%	1.18
	8118081	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-2.62	CHEMBL3935	Homo sapiens	Inhibition	%	-2.62
	8118421	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	-0.05	CHEMBL3935	Homo sapiens	Inhibition	%	-0.05
	8118593	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.53	CHEMBL3935	Homo sapiens	Inhibition	%	4.53
	8118953	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	7.59	CHEMBL3935	Homo sapiens	Inhibition	%	7.59
	8119224	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.55	CHEMBL3935	Homo sapiens	Inhibition	%	-0.55
	8119383	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	92.47	CHEMBL3935	Homo sapiens	Inhibition	%	92.47
	8119774	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-5.73	CHEMBL3935	Homo sapiens	Inhibition	%	-5.73
	8119893	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.51	CHEMBL3935	Homo sapiens	Inhibition	%	2.51
	8120117	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.59	CHEMBL3935	Homo sapiens	Inhibition	%	-0.59
	8120256	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.45	CHEMBL3935	Homo sapiens	Inhibition	%	0.45
	8120416	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	42.99	CHEMBL3935	Homo sapiens	Inhibition	%	42.99
	8120640	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.11	CHEMBL3935	Homo sapiens	Inhibition	%	2.11
	8120841	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.1	CHEMBL3935	Homo sapiens	Inhibition	%	3.1
	8120969	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-4.39	CHEMBL3935	Homo sapiens	Inhibition	%	-4.39
	8121193	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	6.7	CHEMBL3935	Homo sapiens	Inhibition	%	6.7
	8121365	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.18	CHEMBL3935	Homo sapiens	Inhibition	%	-0.18
	8121532	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	5.0	CHEMBL3935	Homo sapiens	Inhibition	%	5.0
	8121756	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	8.21	CHEMBL3935	Homo sapiens	Inhibition	%	8.21
	8121919	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.83	CHEMBL3935	Homo sapiens	Inhibition	%	1.83
	8122040	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	7.9	CHEMBL3935	Homo sapiens	Inhibition	%	7.9
	8122264	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	13.34	CHEMBL3935	Homo sapiens	Inhibition	%	13.34
	8122402	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.92	CHEMBL3935	Homo sapiens	Inhibition	%	4.92
	8122746	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.52	CHEMBL3935	Homo sapiens	Inhibition	%	0.52
	8122913	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.13	CHEMBL3935	Homo sapiens	Inhibition	%	2.13
	8123137	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.42	CHEMBL3935	Homo sapiens	Inhibition	%	1.42
	8123279	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	4.2	CHEMBL3935	Homo sapiens	Inhibition	%	4.2
	8123557	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	12.28	CHEMBL3935	Homo sapiens	Inhibition	%	12.28
	8123707	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	9.9	CHEMBL3935	Homo sapiens	Inhibition	%	9.9
	8123931	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	88.27	CHEMBL3935	Homo sapiens	Inhibition	%	88.27
	8124098	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.73	CHEMBL3935	Homo sapiens	Inhibition	%	0.73
	8124441	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	33.22	CHEMBL3935	Homo sapiens	Inhibition	%	33.22
	8124580	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.78	CHEMBL3935	Homo sapiens	Inhibition	%	1.78
	8124969	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	27.65	CHEMBL3935	Homo sapiens	Inhibition	%	27.65
	8125170	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.29	CHEMBL3935	Homo sapiens	Inhibition	%	1.29
	8125524	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.84	CHEMBL3935	Homo sapiens	Inhibition	%	-1.84
	8125692	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	5.53	CHEMBL3935	Homo sapiens	Inhibition	%	5.53
	8126080	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.94	CHEMBL3935	Homo sapiens	Inhibition	%	0.94
	8126244	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	8.84	CHEMBL3935	Homo sapiens	Inhibition	%	8.84
	8126583	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	68.85	CHEMBL3935	Homo sapiens	Inhibition	%	68.85
	8126719	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	22.48	CHEMBL3935	Homo sapiens	Inhibition	%	22.48
	8126943	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	79.21	CHEMBL3935	Homo sapiens	Inhibition	%	79.21
	8127065	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.06	CHEMBL3935	Homo sapiens	Inhibition	%	0.06
	8127456	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	0.03	CHEMBL3935	Homo sapiens	Inhibition	%	0.03
	8127598	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	35.93	CHEMBL3935	Homo sapiens	Inhibition	%	35.93
	8127886	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.04	CHEMBL3935	Homo sapiens	Inhibition	%	1.04
	8128262	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.08	CHEMBL3935	Homo sapiens	Inhibition	%	3.08
	8128429	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-1.49	CHEMBL3935	Homo sapiens	Inhibition	%	-1.49
	8128772	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	97.29	CHEMBL3935	Homo sapiens	Inhibition	%	97.29
	8128909	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.93	CHEMBL3935	Homo sapiens	Inhibition	%	1.93
	8129133	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	6.2	CHEMBL3935	Homo sapiens	Inhibition	%	6.2
	8129304	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.74	CHEMBL3935	Homo sapiens	Inhibition	%	0.74
	8129493	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.88	CHEMBL3935	Homo sapiens	Inhibition	%	3.88
	8129856	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.75	CHEMBL3935	Homo sapiens	Inhibition	%	3.75
	8130017	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.63	CHEMBL3935	Homo sapiens	Inhibition	%	0.63
	8130241	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.77	CHEMBL3935	Homo sapiens	Inhibition	%	2.77
	8130413	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	5.27	CHEMBL3935	Homo sapiens	Inhibition	%	5.27
	8130573	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	38.04	CHEMBL3935	Homo sapiens	Inhibition	%	38.04
	8130913	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.52	CHEMBL3935	Homo sapiens	Inhibition	%	-0.52
	8131276	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.7	CHEMBL3935	Homo sapiens	Inhibition	%	3.7
	8131396	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.55	CHEMBL3935	Homo sapiens	Inhibition	%	0.55
	8131787	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.54	CHEMBL3935	Homo sapiens	Inhibition	%	5.54
	8131928	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	42.48	CHEMBL3935	Homo sapiens	Inhibition	%	42.48
	8132152	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	88.77	CHEMBL3935	Homo sapiens	Inhibition	%	88.77
	8132214	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	30.11	CHEMBL3935	Homo sapiens	Inhibition	%	30.11
	8132438	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.75	CHEMBL3935	Homo sapiens	Inhibition	%	-3.75
	8132585	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.63	CHEMBL3935	Homo sapiens	Inhibition	%	2.63
	8132753	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	5.27	CHEMBL3935	Homo sapiens	Inhibition	%	5.27
	8132977	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-3.84	CHEMBL3935	Homo sapiens	Inhibition	%	-3.84
	8133098	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.6	CHEMBL3935	Homo sapiens	Inhibition	%	2.6
	8133460	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.43	CHEMBL3935	Homo sapiens	Inhibition	%	1.43
	8133632	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	7.21	CHEMBL3935	Homo sapiens	Inhibition	%	7.21
	8133812	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	88.36	CHEMBL3935	Homo sapiens	Inhibition	%	88.36
	8134036	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	95.34	CHEMBL3935	Homo sapiens	Inhibition	%	95.34
	8134184	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.13	CHEMBL3935	Homo sapiens	Inhibition	%	1.13
	8134568	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.82	CHEMBL3935	Homo sapiens	Inhibition	%	1.82
	8134752	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	6.66	CHEMBL3935	Homo sapiens	Inhibition	%	6.66
	8134912	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	84.58	CHEMBL3935	Homo sapiens	Inhibition	%	84.58
	8135136	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.2	CHEMBL3935	Homo sapiens	Inhibition	%	4.2
	8135251	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.87	CHEMBL3935	Homo sapiens	Inhibition	%	1.87
	8135616	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.68	CHEMBL3935	Homo sapiens	Inhibition	%	8.68
	8135737	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-4.29	CHEMBL3935	Homo sapiens	Inhibition	%	-4.29
	8135961	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-2.03	CHEMBL3935	Homo sapiens	Inhibition	%	-2.03
	8136129	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.31	CHEMBL3935	Homo sapiens	Inhibition	%	0.31
	8136497	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.07	CHEMBL3935	Homo sapiens	Inhibition	%	7.07
	8136787	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.56	CHEMBL3935	Homo sapiens	Inhibition	%	4.56
	8136922	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.19	CHEMBL3935	Homo sapiens	Inhibition	%	3.19
	8137309	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	17.01	CHEMBL3935	Homo sapiens	Inhibition	%	17.01
	8137429	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.42	CHEMBL3935	Homo sapiens	Inhibition	%	4.42
	8137801	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.58	CHEMBL3935	Homo sapiens	Inhibition	%	4.58
	8137967	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.0	CHEMBL3935	Homo sapiens	Inhibition	%	-2.0
	8138370	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.42	CHEMBL3935	Homo sapiens	Inhibition	%	5.42
	8138518	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	16.73	CHEMBL3935	Homo sapiens	Inhibition	%	16.73
	8138900	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.0	CHEMBL3935	Homo sapiens	Inhibition	%	1.0
	8139085	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	61.07	CHEMBL3935	Homo sapiens	Inhibition	%	61.07
	8139468	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	19.56	CHEMBL3935	Homo sapiens	Inhibition	%	19.56
	8139582	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-0.38	CHEMBL3935	Homo sapiens	Inhibition	%	-0.38
	8139806	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.61	CHEMBL3935	Homo sapiens	Inhibition	%	2.61
	8139947	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	0.94	CHEMBL3935	Homo sapiens	Inhibition	%	0.94
	8140294	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.74	CHEMBL3935	Homo sapiens	Inhibition	%	0.74
	8140453	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.9	CHEMBL3935	Homo sapiens	Inhibition	%	3.9
	8140820	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	11.4	CHEMBL3935	Homo sapiens	Inhibition	%	11.4
	8141122	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.6	CHEMBL3935	Homo sapiens	Inhibition	%	0.6
	8141252	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	28.25	CHEMBL3935	Homo sapiens	Inhibition	%	28.25
	8141476	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.88	CHEMBL3935	Homo sapiens	Inhibition	%	1.88
	8141636	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	58.52	CHEMBL3935	Homo sapiens	Inhibition	%	58.52
	8141755	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.26	CHEMBL3935	Homo sapiens	Inhibition	%	-3.26
	8141979	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-9.54	CHEMBL3935	Homo sapiens	Inhibition	%	-9.54
	8142140	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	6.73	CHEMBL3935	Homo sapiens	Inhibition	%	6.73
	8142308	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.91	CHEMBL3935	Homo sapiens	Inhibition	%	0.91
	8142532	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.94	CHEMBL3935	Homo sapiens	Inhibition	%	-1.94
	8142708	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.59	CHEMBL3935	Homo sapiens	Inhibition	%	5.59
	8142857	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.96	CHEMBL3935	Homo sapiens	Inhibition	%	-0.96
	8143081	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.27	CHEMBL3935	Homo sapiens	Inhibition	%	1.27
	8143236	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.25	CHEMBL3935	Homo sapiens	Inhibition	%	0.25
	8143423	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.09	CHEMBL3935	Homo sapiens	Inhibition	%	0.09
	8143647	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.11	CHEMBL3935	Homo sapiens	Inhibition	%	4.11
	8143806	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.89	CHEMBL3935	Homo sapiens	Inhibition	%	3.89
	8144144	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-3.26	CHEMBL3935	Homo sapiens	Inhibition	%	-3.26
	8144283	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.06	CHEMBL3935	Homo sapiens	Inhibition	%	6.06
	8144507	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-0.85	CHEMBL3935	Homo sapiens	Inhibition	%	-0.85
	8144637	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.0	CHEMBL3935	Homo sapiens	Inhibition	%	2.0
	8144790	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-0.67	CHEMBL3935	Homo sapiens	Inhibition	%	-0.67
	8145014	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.97	CHEMBL3935	Homo sapiens	Inhibition	%	1.97
	8145151	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.93	CHEMBL3935	Homo sapiens	Inhibition	%	2.93
	8145464	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	8.2	CHEMBL3935	Homo sapiens	Inhibition	%	8.2
	8145812	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	7.39	CHEMBL3935	Homo sapiens	Inhibition	%	7.39
	8145973	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%		CHEMBL3935	Homo sapiens	Inhibition	%	
	8146317	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.09	CHEMBL3935	Homo sapiens	Inhibition	%	1.09
	8146477	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	46.76	CHEMBL3935	Homo sapiens	Inhibition	%	46.76
	8146868	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.8	CHEMBL3935	Homo sapiens	Inhibition	%	0.8
	8147037	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.73	CHEMBL3935	Homo sapiens	Inhibition	%	3.73
	8147403	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.82	CHEMBL3935	Homo sapiens	Inhibition	%	1.82
	8147556	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.24	CHEMBL3935	Homo sapiens	Inhibition	%	2.24
	8147967	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-0.01	CHEMBL3935	Homo sapiens	Inhibition	%	-0.01
	8148125	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	9.67	CHEMBL3935	Homo sapiens	Inhibition	%	9.67
	8148463	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.56	CHEMBL3935	Homo sapiens	Inhibition	%	1.56
	8148826	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.1	CHEMBL3935	Homo sapiens	Inhibition	%	4.1
	8148964	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.2	CHEMBL3935	Homo sapiens	Inhibition	%	2.2
	8149347	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-4.78	CHEMBL3935	Homo sapiens	Inhibition	%	-4.78
	8149481	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	10.25	CHEMBL3935	Homo sapiens	Inhibition	%	10.25
	8149705	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	0.6	CHEMBL3935	Homo sapiens	Inhibition	%	0.6
	8149803	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.65	CHEMBL3935	Homo sapiens	Inhibition	%	0.65
	8150152	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	8.04	CHEMBL3935	Homo sapiens	Inhibition	%	8.04
	8150312	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	104.02	CHEMBL3935	Homo sapiens	Inhibition	%	104.02
	8150656	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	6.4	CHEMBL3935	Homo sapiens	Inhibition	%	6.4
	8150821	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.46	CHEMBL3935	Homo sapiens	Inhibition	%	1.46
	8151045	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.53	CHEMBL3935	Homo sapiens	Inhibition	%	2.53
	8151208	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.29	CHEMBL3935	Homo sapiens	Inhibition	%	-3.29
	8151385	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.17	CHEMBL3935	Homo sapiens	Inhibition	%	5.17
	8151609	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.06	CHEMBL3935	Homo sapiens	Inhibition	%	3.06
	8151747	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	10.18	CHEMBL3935	Homo sapiens	Inhibition	%	10.18
	8151901	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.98	CHEMBL3935	Homo sapiens	Inhibition	%	1.98
	8152125	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.91	CHEMBL3935	Homo sapiens	Inhibition	%	5.91
	8152313	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	15.23	CHEMBL3935	Homo sapiens	Inhibition	%	15.23
	8152471	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.81	CHEMBL3935	Homo sapiens	Inhibition	%	0.81
	8152695	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	16.04	CHEMBL3935	Homo sapiens	Inhibition	%	16.04
	8152809	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.61	CHEMBL3935	Homo sapiens	Inhibition	%	6.61
	8153172	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.18	CHEMBL3935	Homo sapiens	Inhibition	%	4.18
	8153309	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.43	CHEMBL3935	Homo sapiens	Inhibition	%	0.43
	8153533	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	-0.51	CHEMBL3935	Homo sapiens	Inhibition	%	-0.51
	8153690	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.4	CHEMBL3935	Homo sapiens	Inhibition	%	1.4
	8154047	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.56	CHEMBL3935	Homo sapiens	Inhibition	%	5.56
	8154144	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	9.48	CHEMBL3935	Homo sapiens	Inhibition	%	9.48
	8154368	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-0.58	CHEMBL3935	Homo sapiens	Inhibition	%	-0.58
	8154494	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	82.36	CHEMBL3935	Homo sapiens	Inhibition	%	82.36
	8154653	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.94	CHEMBL3935	Homo sapiens	Inhibition	%	1.94
	8154877	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-5.97	CHEMBL3935	Homo sapiens	Inhibition	%	-5.97
	8154997	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.56	CHEMBL3935	Homo sapiens	Inhibition	%	0.56
	8155397	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.04	CHEMBL3935	Homo sapiens	Inhibition	%	1.04
	8155558	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.5	CHEMBL3935	Homo sapiens	Inhibition	%	0.5
	8155960	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	24.82	CHEMBL3935	Homo sapiens	Inhibition	%	24.82
	8156098	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.6	CHEMBL3935	Homo sapiens	Inhibition	%	2.6
	8156310	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	10.11	CHEMBL3935	Homo sapiens	Inhibition	%	10.11
	8156534	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.4	CHEMBL3935	Homo sapiens	Inhibition	%	2.4
	8156684	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-0.45	CHEMBL3935	Homo sapiens	Inhibition	%	-0.45
	8157051	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	54.46	CHEMBL3935	Homo sapiens	Inhibition	%	54.46
	8157171	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	7.71	CHEMBL3935	Homo sapiens	Inhibition	%	7.71
	8157395	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	78.22	CHEMBL3935	Homo sapiens	Inhibition	%	78.22
	8157536	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.2	CHEMBL3935	Homo sapiens	Inhibition	%	1.2
	8157890	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	0.97	CHEMBL3935	Homo sapiens	Inhibition	%	0.97
	8158051	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	16.16	CHEMBL3935	Homo sapiens	Inhibition	%	16.16
	8158301	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	12.65	CHEMBL3935	Homo sapiens	Inhibition	%	12.65
	8158683	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	7.12	CHEMBL3935	Homo sapiens	Inhibition	%	7.12
	8158852	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.12	CHEMBL3935	Homo sapiens	Inhibition	%	0.12
	8159211	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.9	CHEMBL3935	Homo sapiens	Inhibition	%	1.9
	8159331	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	7.15	CHEMBL3935	Homo sapiens	Inhibition	%	7.15
	8159555	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-4.05	CHEMBL3935	Homo sapiens	Inhibition	%	-4.05
	8159686	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	19.57	CHEMBL3935	Homo sapiens	Inhibition	%	19.57
	8160051	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-3.23	CHEMBL3935	Homo sapiens	Inhibition	%	-3.23
	8160188	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.31	CHEMBL3935	Homo sapiens	Inhibition	%	2.31
	8160562	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.77	CHEMBL3935	Homo sapiens	Inhibition	%	-1.77
	8160856	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	19.25	CHEMBL3935	Homo sapiens	Inhibition	%	19.25
	8161006	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	43.77	CHEMBL3935	Homo sapiens	Inhibition	%	43.77
	8161373	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	18.77	CHEMBL3935	Homo sapiens	Inhibition	%	18.77
	8161722	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.84	CHEMBL3935	Homo sapiens	Inhibition	%	1.84
	8161860	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	11.35	CHEMBL3935	Homo sapiens	Inhibition	%	11.35
	8162214	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-1.48	CHEMBL3935	Homo sapiens	Inhibition	%	-1.48
	8162374	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-5.06	CHEMBL3935	Homo sapiens	Inhibition	%	-5.06
	8162598	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	23.68	CHEMBL3935	Homo sapiens	Inhibition	%	23.68
	8162627	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.58	CHEMBL3935	Homo sapiens	Inhibition	%	1.58
	8162851	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-2.29	CHEMBL3935	Homo sapiens	Inhibition	%	-2.29
	8162999	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	28.37	CHEMBL3935	Homo sapiens	Inhibition	%	28.37
	8163168	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	8.07	CHEMBL3935	Homo sapiens	Inhibition	%	8.07
	8163392	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.03	CHEMBL3935	Homo sapiens	Inhibition	%	1.03
	8163526	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.83	CHEMBL3935	Homo sapiens	Inhibition	%	5.83
	8163873	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-8.58	CHEMBL3935	Homo sapiens	Inhibition	%	-8.58
	8164007	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-0.09	CHEMBL3935	Homo sapiens	Inhibition	%	-0.09
	8164231	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	5.81	CHEMBL3935	Homo sapiens	Inhibition	%	5.81
	8164371	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.39	CHEMBL3935	Homo sapiens	Inhibition	%	-0.39
	8164526	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	-1.84	CHEMBL3935	Homo sapiens	Inhibition	%	-1.84
	8164750	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	18.5	CHEMBL3935	Homo sapiens	Inhibition	%	18.5
	8164894	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-2.2	CHEMBL3935	Homo sapiens	Inhibition	%	-2.2
	8165188	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.36	CHEMBL3935	Homo sapiens	Inhibition	%	2.36
	8165329	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	104.4	CHEMBL3935	Homo sapiens	Inhibition	%	104.4
	8165553	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.54	CHEMBL3935	Homo sapiens	Inhibition	%	4.54
	8165696	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	96.8	CHEMBL3935	Homo sapiens	Inhibition	%	96.8
	8166046	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	7.14	CHEMBL3935	Homo sapiens	Inhibition	%	7.14
	8166184	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.7	CHEMBL3935	Homo sapiens	Inhibition	%	0.7
	8166408	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.46	CHEMBL3935	Homo sapiens	Inhibition	%	0.46
	8166538	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.05	CHEMBL3935	Homo sapiens	Inhibition	%	2.05
	8166863	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	79.7	CHEMBL3935	Homo sapiens	Inhibition	%	79.7
	8167175	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.52	CHEMBL3935	Homo sapiens	Inhibition	%	1.52
	8167316	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	92.18	CHEMBL3935	Homo sapiens	Inhibition	%	92.18
	8167704	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.63	CHEMBL3935	Homo sapiens	Inhibition	%	2.63
	8167837	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.48	CHEMBL3935	Homo sapiens	Inhibition	%	1.48
	8168185	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.09	CHEMBL3935	Homo sapiens	Inhibition	%	2.09
	8168550	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.74	CHEMBL3935	Homo sapiens	Inhibition	%	0.74
	8168686	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-1.87	CHEMBL3935	Homo sapiens	Inhibition	%	-1.87
	8169074	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	96.67	CHEMBL3935	Homo sapiens	Inhibition	%	96.67
	8169216	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.71	CHEMBL3935	Homo sapiens	Inhibition	%	1.71
	8169520	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.16	CHEMBL3935	Homo sapiens	Inhibition	%	4.16
	8169878	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-3.03	CHEMBL3935	Homo sapiens	Inhibition	%	-3.03
	8170023	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.5	CHEMBL3935	Homo sapiens	Inhibition	%	1.5
	8170247	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	79.68	CHEMBL3935	Homo sapiens	Inhibition	%	79.68
	8170372	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.56	CHEMBL3935	Homo sapiens	Inhibition	%	2.56
	8170736	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-3.33	CHEMBL3935	Homo sapiens	Inhibition	%	-3.33
	8170871	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	-2.07	CHEMBL3935	Homo sapiens	Inhibition	%	-2.07
	8171292	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	7.34	CHEMBL3935	Homo sapiens	Inhibition	%	7.34
	8171509	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.33	CHEMBL3935	Homo sapiens	Inhibition	%	4.33
	8171650	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.7	CHEMBL3935	Homo sapiens	Inhibition	%	4.7
	8171874	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	13.68	CHEMBL3935	Homo sapiens	Inhibition	%	13.68
	8172027	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-2.12	CHEMBL3935	Homo sapiens	Inhibition	%	-2.12
	8172159	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-2.72	CHEMBL3935	Homo sapiens	Inhibition	%	-2.72
	8172383	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.06	CHEMBL3935	Homo sapiens	Inhibition	%	9.06
	8172511	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	26.95	CHEMBL3935	Homo sapiens	Inhibition	%	26.95
	8172877	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.84	CHEMBL3935	Homo sapiens	Inhibition	%	6.84
	8173013	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.44	CHEMBL3935	Homo sapiens	Inhibition	%	-1.44
	8173237	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.43	CHEMBL3935	Homo sapiens	Inhibition	%	2.43
	8173402	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.33	CHEMBL3935	Homo sapiens	Inhibition	%	7.33
	8173543	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	23.31	CHEMBL3935	Homo sapiens	Inhibition	%	23.31
	8173767	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.6	CHEMBL3935	Homo sapiens	Inhibition	%	2.6
	8173854	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.9	CHEMBL3935	Homo sapiens	Inhibition	%	3.9
	8174078	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	31.52	CHEMBL3935	Homo sapiens	Inhibition	%	31.52
	8174210	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.3	CHEMBL3935	Homo sapiens	Inhibition	%	2.3
	8174582	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.57	CHEMBL3935	Homo sapiens	Inhibition	%	0.57
	8174704	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	12.09	CHEMBL3935	Homo sapiens	Inhibition	%	12.09
	8175071	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F	Outside typical range	CHEMBL1794065	=	Inhibition	%	-10.37	CHEMBL3935	Homo sapiens	Inhibition	%	-10.37
	8175207	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	5.11	CHEMBL3935	Homo sapiens	Inhibition	%	5.11
	8175431	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	74.59	CHEMBL3935	Homo sapiens	Inhibition	%	74.59
	8175463	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.93	CHEMBL3935	Homo sapiens	Inhibition	%	3.93
	8175687	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	44.79	CHEMBL3935	Homo sapiens	Inhibition	%	44.79
	8175850	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	13.3	CHEMBL3935	Homo sapiens	Inhibition	%	13.3
	8176227	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.83	CHEMBL3935	Homo sapiens	Inhibition	%	3.83
	8176376	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.75	CHEMBL3935	Homo sapiens	Inhibition	%	1.75
	8176732	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	81.86	CHEMBL3935	Homo sapiens	Inhibition	%	81.86
	8176862	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.04	CHEMBL3935	Homo sapiens	Inhibition	%	1.04
	8177086	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	7.73	CHEMBL3935	Homo sapiens	Inhibition	%	7.73
	8177228	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-3.31	CHEMBL3935	Homo sapiens	Inhibition	%	-3.31
	8177590	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	12.39	CHEMBL3935	Homo sapiens	Inhibition	%	12.39
	8177754	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	61.4	CHEMBL3935	Homo sapiens	Inhibition	%	61.4
	8178118	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	31.67	CHEMBL3935	Homo sapiens	Inhibition	%	31.67
	8178430	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.15	CHEMBL3935	Homo sapiens	Inhibition	%	2.15
	8178557	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-1.31	CHEMBL3935	Homo sapiens	Inhibition	%	-1.31
	8178930	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	11.83	CHEMBL3935	Homo sapiens	Inhibition	%	11.83
	8179053	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.85	CHEMBL3935	Homo sapiens	Inhibition	%	1.85
	8179277	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	12.02	CHEMBL3935	Homo sapiens	Inhibition	%	12.02
	8179421	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.92	CHEMBL3935	Homo sapiens	Inhibition	%	1.92
	8179782	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.17	CHEMBL3935	Homo sapiens	Inhibition	%	1.17
	8180039	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.39	CHEMBL3935	Homo sapiens	Inhibition	%	4.39
	8180193	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	93.03	CHEMBL3935	Homo sapiens	Inhibition	%	93.03
	8180573	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	18.75	CHEMBL3935	Homo sapiens	Inhibition	%	18.75
	8180721	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	17.88	CHEMBL3935	Homo sapiens	Inhibition	%	17.88
	8180945	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	47.98	CHEMBL3935	Homo sapiens	Inhibition	%	47.98
	8181078	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	0.93	CHEMBL3935	Homo sapiens	Inhibition	%	0.93
	8181433	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	7.34	CHEMBL3935	Homo sapiens	Inhibition	%	7.34
	8181573	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-0.15	CHEMBL3935	Homo sapiens	Inhibition	%	-0.15
	8181936	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	86.82	CHEMBL3935	Homo sapiens	Inhibition	%	86.82
	8182099	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.74	CHEMBL3935	Homo sapiens	Inhibition	%	2.74
	8182323	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-0.03	CHEMBL3935	Homo sapiens	Inhibition	%	-0.03
	8182463	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.92	CHEMBL3935	Homo sapiens	Inhibition	%	2.92
	8182779	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	8.8	CHEMBL3935	Homo sapiens	Inhibition	%	8.8
	8182901	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.64	CHEMBL3935	Homo sapiens	Inhibition	%	2.64
	8183125	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.29	CHEMBL3935	Homo sapiens	Inhibition	%	3.29
	8183274	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.61	CHEMBL3935	Homo sapiens	Inhibition	%	1.61
	8183627	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.98	CHEMBL3935	Homo sapiens	Inhibition	%	4.98
	8183769	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	14.64	CHEMBL3935	Homo sapiens	Inhibition	%	14.64
	8184129	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.04	CHEMBL3935	Homo sapiens	Inhibition	%	5.04
	8184395	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-2.07	CHEMBL3935	Homo sapiens	Inhibition	%	-2.07
	8184542	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.76	CHEMBL3935	Homo sapiens	Inhibition	%	-2.76
	8184766	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.08	CHEMBL3935	Homo sapiens	Inhibition	%	-2.08
	8184923	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.04	CHEMBL3935	Homo sapiens	Inhibition	%	1.04
	8185296	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.0	CHEMBL3935	Homo sapiens	Inhibition	%	1.0
	8185427	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	-0.69	CHEMBL3935	Homo sapiens	Inhibition	%	-0.69
	8185782	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	85.68	CHEMBL3935	Homo sapiens	Inhibition	%	85.68
	8185921	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.96	CHEMBL3935	Homo sapiens	Inhibition	%	0.96
	8186145	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	9.67	CHEMBL3935	Homo sapiens	Inhibition	%	9.67
	8186286	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.75	CHEMBL3935	Homo sapiens	Inhibition	%	1.75
	8186674	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.68	CHEMBL3935	Homo sapiens	Inhibition	%	1.68
	8186813	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	12.93	CHEMBL3935	Homo sapiens	Inhibition	%	12.93
	8187135	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	8.73	CHEMBL3935	Homo sapiens	Inhibition	%	8.73
	8187483	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.02	CHEMBL3935	Homo sapiens	Inhibition	%	2.02
	8187631	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	14.62	CHEMBL3935	Homo sapiens	Inhibition	%	14.62
	8187984	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	12.12	CHEMBL3935	Homo sapiens	Inhibition	%	12.12
	8188127	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.97	CHEMBL3935	Homo sapiens	Inhibition	%	1.97
	8188351	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.64	CHEMBL3935	Homo sapiens	Inhibition	%	5.64
	8188486	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.72	CHEMBL3935	Homo sapiens	Inhibition	%	0.72
	8188760	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.42	CHEMBL3935	Homo sapiens	Inhibition	%	3.42
	8189132	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.77	CHEMBL3935	Homo sapiens	Inhibition	%	1.77
	8189288	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	22.86	CHEMBL3935	Homo sapiens	Inhibition	%	22.86
	8189661	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-2.37	CHEMBL3935	Homo sapiens	Inhibition	%	-2.37
	8189793	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-2.83	CHEMBL3935	Homo sapiens	Inhibition	%	-2.83
	8190017	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-5.69	CHEMBL3935	Homo sapiens	Inhibition	%	-5.69
	8190149	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	7.31	CHEMBL3935	Homo sapiens	Inhibition	%	7.31
	8190513	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.71	CHEMBL3935	Homo sapiens	Inhibition	%	1.71
	8190650	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	6.44	CHEMBL3935	Homo sapiens	Inhibition	%	6.44
	8190874	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.22	CHEMBL3935	Homo sapiens	Inhibition	%	1.22
	8191038	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	-3.65	CHEMBL3935	Homo sapiens	Inhibition	%	-3.65
	8191176	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	21.9	CHEMBL3935	Homo sapiens	Inhibition	%	21.9
	8191400	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	94.53	CHEMBL3935	Homo sapiens	Inhibition	%	94.53
	8191496	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.85	CHEMBL3935	Homo sapiens	Inhibition	%	1.85
	8191842	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	56.85	CHEMBL3935	Homo sapiens	Inhibition	%	56.85
	8191991	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.82	CHEMBL3935	Homo sapiens	Inhibition	%	0.82
	8192215	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	11.66	CHEMBL3935	Homo sapiens	Inhibition	%	11.66
	8192344	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.85	CHEMBL3935	Homo sapiens	Inhibition	%	2.85
	8192712	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.1	CHEMBL3935	Homo sapiens	Inhibition	%	2.1
	8192848	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	12.22	CHEMBL3935	Homo sapiens	Inhibition	%	12.22
	8193072	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.08	CHEMBL3935	Homo sapiens	Inhibition	%	1.08
	8193120	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	40.47	CHEMBL3935	Homo sapiens	Inhibition	%	40.47
	8193344	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-0.44	CHEMBL3935	Homo sapiens	Inhibition	%	-0.44
	8193489	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	13.8	CHEMBL3935	Homo sapiens	Inhibition	%	13.8
	8193646	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.7	CHEMBL3935	Homo sapiens	Inhibition	%	7.7
	8193870	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	76.66	CHEMBL3935	Homo sapiens	Inhibition	%	76.66
	8194019	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.17	CHEMBL3935	Homo sapiens	Inhibition	%	0.17
	8194374	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.17	CHEMBL3935	Homo sapiens	Inhibition	%	1.17
	8194505	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	87.54	CHEMBL3935	Homo sapiens	Inhibition	%	87.54
	8194729	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.07	CHEMBL3935	Homo sapiens	Inhibition	%	3.07
	8194872	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.08	CHEMBL3935	Homo sapiens	Inhibition	%	5.08
	8195229	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-3.16	CHEMBL3935	Homo sapiens	Inhibition	%	-3.16
	8195393	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.45	CHEMBL3935	Homo sapiens	Inhibition	%	3.45
	8195756	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.67	CHEMBL3935	Homo sapiens	Inhibition	%	3.67
	8195854	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.47	CHEMBL3935	Homo sapiens	Inhibition	%	3.47
	8196078	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	21.32	CHEMBL3935	Homo sapiens	Inhibition	%	21.32
	8196195	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.08	CHEMBL3935	Homo sapiens	Inhibition	%	4.08
	8196569	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.67	CHEMBL3935	Homo sapiens	Inhibition	%	2.67
	8196697	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-5.63	CHEMBL3935	Homo sapiens	Inhibition	%	-5.63
	8196921	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.54	CHEMBL3935	Homo sapiens	Inhibition	%	-0.54
	8197062	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	-3.67	CHEMBL3935	Homo sapiens	Inhibition	%	-3.67
	8197423	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	4.09	CHEMBL3935	Homo sapiens	Inhibition	%	4.09
	8197698	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-4.53	CHEMBL3935	Homo sapiens	Inhibition	%	-4.53
	8197838	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.35	CHEMBL3935	Homo sapiens	Inhibition	%	2.35
	8198219	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.97	CHEMBL3935	Homo sapiens	Inhibition	%	-1.97
	8198357	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.42	CHEMBL3935	Homo sapiens	Inhibition	%	-2.42
	8198711	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.32	CHEMBL3935	Homo sapiens	Inhibition	%	4.32
	8199066	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	15.86	CHEMBL3935	Homo sapiens	Inhibition	%	15.86
	8199214	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.94	CHEMBL3935	Homo sapiens	Inhibition	%	5.94
	8199572	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.15	CHEMBL3935	Homo sapiens	Inhibition	%	1.15
	8199735	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	36.68	CHEMBL3935	Homo sapiens	Inhibition	%	36.68
	8200097	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	12.5	CHEMBL3935	Homo sapiens	Inhibition	%	12.5
	8200425	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.35	CHEMBL3935	Homo sapiens	Inhibition	%	1.35
	8200540	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	7.02	CHEMBL3935	Homo sapiens	Inhibition	%	7.02
	8200764	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	6.8	CHEMBL3935	Homo sapiens	Inhibition	%	6.8
	8200914	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	25.24	CHEMBL3935	Homo sapiens	Inhibition	%	25.24
	8201268	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	10.07	CHEMBL3935	Homo sapiens	Inhibition	%	10.07
	8201403	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.1	CHEMBL3935	Homo sapiens	Inhibition	%	-0.1
	8201760	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.11	CHEMBL3935	Homo sapiens	Inhibition	%	-0.11
	8202039	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.77	CHEMBL3935	Homo sapiens	Inhibition	%	0.77
	8202179	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	40.53	CHEMBL3935	Homo sapiens	Inhibition	%	40.53
	8202403	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.77	CHEMBL3935	Homo sapiens	Inhibition	%	-0.77
	8202570	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	13.58	CHEMBL3935	Homo sapiens	Inhibition	%	13.58
	8202695	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-0.57	CHEMBL3935	Homo sapiens	Inhibition	%	-0.57
	8202919	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-4.87	CHEMBL3935	Homo sapiens	Inhibition	%	-4.87
	8203049	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.24	CHEMBL3935	Homo sapiens	Inhibition	%	1.24
	8203404	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	15.81	CHEMBL3935	Homo sapiens	Inhibition	%	15.81
	8203550	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	40.27	CHEMBL3935	Homo sapiens	Inhibition	%	40.27
	8203774	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-0.51	CHEMBL3935	Homo sapiens	Inhibition	%	-0.51
	8203908	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	-2.38	CHEMBL3935	Homo sapiens	Inhibition	%	-2.38
	8204074	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.94	CHEMBL3935	Homo sapiens	Inhibition	%	0.94
	8204298	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	-1.91	CHEMBL3935	Homo sapiens	Inhibition	%	-1.91
	8204435	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.76	CHEMBL3935	Homo sapiens	Inhibition	%	6.76
	8204764	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	36.06	CHEMBL3935	Homo sapiens	Inhibition	%	36.06
	8205103	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	65.97	CHEMBL3935	Homo sapiens	Inhibition	%	65.97
	8205252	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	7.39	CHEMBL3935	Homo sapiens	Inhibition	%	7.39
	8205612	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.28	CHEMBL3935	Homo sapiens	Inhibition	%	2.28
	8205751	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-6.92	CHEMBL3935	Homo sapiens	Inhibition	%	-6.92
	8205975	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.19	CHEMBL3935	Homo sapiens	Inhibition	%	1.19
	8206107	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.95	CHEMBL3935	Homo sapiens	Inhibition	%	2.95
	8206383	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-1.89	CHEMBL3935	Homo sapiens	Inhibition	%	-1.89
	8206750	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	9.45	CHEMBL3935	Homo sapiens	Inhibition	%	9.45
	8206930	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.95	CHEMBL3935	Homo sapiens	Inhibition	%	0.95
	8207280	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.1	CHEMBL3935	Homo sapiens	Inhibition	%	1.1
	8207410	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-1.21	CHEMBL3935	Homo sapiens	Inhibition	%	-1.21
	8207634	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.12	CHEMBL3935	Homo sapiens	Inhibition	%	2.12
	8207766	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	81.63	CHEMBL3935	Homo sapiens	Inhibition	%	81.63
	8208135	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.86	CHEMBL3935	Homo sapiens	Inhibition	%	1.86
	8208267	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.12	CHEMBL3935	Homo sapiens	Inhibition	%	2.12
	8208657	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.09	CHEMBL3935	Homo sapiens	Inhibition	%	3.09
	8208790	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	60.61	CHEMBL3935	Homo sapiens	Inhibition	%	60.61
	8209014	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.22	CHEMBL3935	Homo sapiens	Inhibition	%	4.22
	8209119	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.45	CHEMBL3935	Homo sapiens	Inhibition	%	0.45
	8209459	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.42	CHEMBL3935	Homo sapiens	Inhibition	%	2.42
	8209609	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	75.45	CHEMBL3935	Homo sapiens	Inhibition	%	75.45
	8209833	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.15	CHEMBL3935	Homo sapiens	Inhibition	%	1.15
	8209969	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	-5.69	CHEMBL3935	Homo sapiens	Inhibition	%	-5.69
	8210334	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-2.19	CHEMBL3935	Homo sapiens	Inhibition	%	-2.19
	8210470	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.4	CHEMBL3935	Homo sapiens	Inhibition	%	-1.4
	8210729	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-2.03	CHEMBL3935	Homo sapiens	Inhibition	%	-2.03
	8211097	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	5.23	CHEMBL3935	Homo sapiens	Inhibition	%	5.23
	8211267	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.01	CHEMBL3935	Homo sapiens	Inhibition	%	6.01
	8211614	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-2.15	CHEMBL3935	Homo sapiens	Inhibition	%	-2.15
	8211967	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	8.73	CHEMBL3935	Homo sapiens	Inhibition	%	8.73
	8212099	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	8.37	CHEMBL3935	Homo sapiens	Inhibition	%	8.37
	8212464	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.6	CHEMBL3935	Homo sapiens	Inhibition	%	0.6
	8212597	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-1.66	CHEMBL3935	Homo sapiens	Inhibition	%	-1.66
	8212821	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.3	CHEMBL3935	Homo sapiens	Inhibition	%	1.3
	8212991	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	32.81	CHEMBL3935	Homo sapiens	Inhibition	%	32.81
	8213344	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	11.63	CHEMBL3935	Homo sapiens	Inhibition	%	11.63
	8213448	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.17	CHEMBL3935	Homo sapiens	Inhibition	%	-0.17
	8213672	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.78	CHEMBL3935	Homo sapiens	Inhibition	%	-1.78
	8213785	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1	Outside typical range	CHEMBL181361	=	Inhibition	%	-13.31	CHEMBL3935	Homo sapiens	Inhibition	%	-13.31
	8214156	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	14.39	CHEMBL3935	Homo sapiens	Inhibition	%	14.39
	8214293	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.62	CHEMBL3935	Homo sapiens	Inhibition	%	4.62
	8214651	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	8.25	CHEMBL3935	Homo sapiens	Inhibition	%	8.25
	8214803	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.08	CHEMBL3935	Homo sapiens	Inhibition	%	-3.08
	8215027	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.43	CHEMBL3935	Homo sapiens	Inhibition	%	5.43
	8215054	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-9.49	CHEMBL3935	Homo sapiens	Inhibition	%	-9.49
	8215278	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.25	CHEMBL3935	Homo sapiens	Inhibition	%	0.25
	8215431	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	54.87	CHEMBL3935	Homo sapiens	Inhibition	%	54.87
	8215595	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.44	CHEMBL3935	Homo sapiens	Inhibition	%	1.44
	8215819	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	9.49	CHEMBL3935	Homo sapiens	Inhibition	%	9.49
	8215938	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-2.54	CHEMBL3935	Homo sapiens	Inhibition	%	-2.54
	8216281	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.7	CHEMBL3935	Homo sapiens	Inhibition	%	-0.7
	8216417	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	12.41	CHEMBL3935	Homo sapiens	Inhibition	%	12.41
	8216641	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	53.71	CHEMBL3935	Homo sapiens	Inhibition	%	53.71
	8216779	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.95	CHEMBL3935	Homo sapiens	Inhibition	%	6.95
	8217137	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-4.74	CHEMBL3935	Homo sapiens	Inhibition	%	-4.74
	8217311	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.67	CHEMBL3935	Homo sapiens	Inhibition	%	0.67
	8217666	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	17.73	CHEMBL3935	Homo sapiens	Inhibition	%	17.73
	8217991	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.59	CHEMBL3935	Homo sapiens	Inhibition	%	-3.59
	8218106	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.74	CHEMBL3935	Homo sapiens	Inhibition	%	1.74
	8218457	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	5.58	CHEMBL3935	Homo sapiens	Inhibition	%	5.58
	8218600	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	50.74	CHEMBL3935	Homo sapiens	Inhibition	%	50.74
	8218824	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.56	CHEMBL3935	Homo sapiens	Inhibition	%	3.56
	8218955	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	85.42	CHEMBL3935	Homo sapiens	Inhibition	%	85.42
	8219339	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	18.16	CHEMBL3935	Homo sapiens	Inhibition	%	18.16
	8219589	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-2.92	CHEMBL3935	Homo sapiens	Inhibition	%	-2.92
	8219750	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.56	CHEMBL3935	Homo sapiens	Inhibition	%	1.56
	8220143	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.9	CHEMBL3935	Homo sapiens	Inhibition	%	1.9
	8220272	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-7.09	CHEMBL3935	Homo sapiens	Inhibition	%	-7.09
	8220496	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.49	CHEMBL3935	Homo sapiens	Inhibition	%	1.49
	8220610	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-6.73	CHEMBL3935	Homo sapiens	Inhibition	%	-6.73
	8220972	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	93.39	CHEMBL3935	Homo sapiens	Inhibition	%	93.39
	8221108	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-3.73	CHEMBL3935	Homo sapiens	Inhibition	%	-3.73
	8221332	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.49	CHEMBL3935	Homo sapiens	Inhibition	%	-0.49
	8221465	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	0.7	CHEMBL3935	Homo sapiens	Inhibition	%	0.7
	8221630	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-1.26	CHEMBL3935	Homo sapiens	Inhibition	%	-1.26
	8221854	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.01	CHEMBL3935	Homo sapiens	Inhibition	%	-0.01
	8221985	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	93.8	CHEMBL3935	Homo sapiens	Inhibition	%	93.8
	8222307	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	4.6	CHEMBL3935	Homo sapiens	Inhibition	%	4.6
	8222441	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	-1.31	CHEMBL3935	Homo sapiens	Inhibition	%	-1.31
	8222665	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	6.57	CHEMBL3935	Homo sapiens	Inhibition	%	6.57
	8222783	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	57.0	CHEMBL3935	Homo sapiens	Inhibition	%	57.0
	8223151	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	76.22	CHEMBL3935	Homo sapiens	Inhibition	%	76.22
	8223280	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.42	CHEMBL3935	Homo sapiens	Inhibition	%	3.42
	8223504	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	40.77	CHEMBL3935	Homo sapiens	Inhibition	%	40.77
	8223665	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.97	CHEMBL3935	Homo sapiens	Inhibition	%	2.97
	8223915	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.31	CHEMBL3935	Homo sapiens	Inhibition	%	1.31
	8224077	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	15.26	CHEMBL3935	Homo sapiens	Inhibition	%	15.26
	8224301	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.41	CHEMBL3935	Homo sapiens	Inhibition	%	-0.41
	8224471	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.78	CHEMBL3935	Homo sapiens	Inhibition	%	4.78
	8224830	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-6.13	CHEMBL3935	Homo sapiens	Inhibition	%	-6.13
	8224944	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	0.68	CHEMBL3935	Homo sapiens	Inhibition	%	0.68
	8225302	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.83	CHEMBL3935	Homo sapiens	Inhibition	%	7.83
	8225664	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.37	CHEMBL3935	Homo sapiens	Inhibition	%	0.37
	8225799	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-0.44	CHEMBL3935	Homo sapiens	Inhibition	%	-0.44
	8226181	CHEMBL1962199	GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.08	CHEMBL3935	Homo sapiens	Inhibition	%	-3.08
	8226306	CHEMBL1962198	GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.04	CHEMBL3935	Homo sapiens	Inhibition	%	3.04
	10838651	CHEMBL2014529	Inhibition of AurC at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	1.0	CHEMBL3935	Homo sapiens	INH	%	1.0
	10853973	CHEMBL2020364	Inhibition of AURKC at 10 uM relative to control	B	Cc1ccc(S(=O)(=O)n2c(N)nc3ccccc32)cc1		CHEMBL1412853	=	Inhibition	%	23.0	CHEMBL3935	Homo sapiens	INH	%	23.0
	11011602	CHEMBL2091235	Inhibition of Aurora kinase C at 10 uM by luciferase assay	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	>	Inhibition	%	25.0	CHEMBL3935	Homo sapiens	INH	%	25.0
	11011604	CHEMBL2091235	Inhibition of Aurora kinase C at 10 uM by luciferase assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Inhibition	%	25.0	CHEMBL3935	Homo sapiens	INH	%	25.0
	11011607	CHEMBL2091235	Inhibition of Aurora kinase C at 10 uM by luciferase assay	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	>	Inhibition	%	25.0	CHEMBL3935	Homo sapiens	INH	%	25.0
	11011615	CHEMBL2091235	Inhibition of Aurora kinase C at 10 uM by luciferase assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	>	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	12046243	CHEMBL2157263	Inhibition of Aurora C at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	1.1	CHEMBL3935	Homo sapiens	INH	%	1.1
	12086163	CHEMBL2168186	Binding affinity to Aurora kinase C	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163394	<	Kd	nM	10.0	CHEMBL3935	Homo sapiens	Kd	nM	10.0
	12086164	CHEMBL2168186	Binding affinity to Aurora kinase C	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(F)(F)C5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163404	<	Kd	nM	10.0	CHEMBL3935	Homo sapiens	Kd	nM	10.0
	12112598	CHEMBL2174420	Inhibition of Aurora C kinase at 1 uM by 33P kinase hotspot assay	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	=	Inhibition	%	84.0	CHEMBL3935	Homo sapiens	INH	%	84.0
	12112599	CHEMBL2174420	Inhibition of Aurora C kinase at 1 uM by 33P kinase hotspot assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	86.0	CHEMBL3935	Homo sapiens	INH	%	86.0
	12173731	CHEMBL2212069	Inhibition of AURKC assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	75.0	CHEMBL3935	Homo sapiens	Activity	%	75.0
	12216739	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	115.0	CHEMBL3935	Homo sapiens	Residual Activity	%	115.0
	12216740	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	114.0	CHEMBL3935	Homo sapiens	Residual Activity	%	114.0
	12216741	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12216742	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL3935	Homo sapiens	Residual Activity	%	101.0
	12216743	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	85.0	CHEMBL3935	Homo sapiens	Residual Activity	%	85.0
	12216744	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL3935	Homo sapiens	Residual Activity	%	97.0
	12216745	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	40.0	CHEMBL3935	Homo sapiens	Residual Activity	%	40.0
	12216746	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	100.0	CHEMBL3935	Homo sapiens	Residual Activity	%	100.0
	12216747	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	102.0	CHEMBL3935	Homo sapiens	Residual Activity	%	102.0
	12216748	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	80.0	CHEMBL3935	Homo sapiens	Residual Activity	%	80.0
	12216749	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	99.0	CHEMBL3935	Homo sapiens	Residual Activity	%	99.0
	12216750	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12216751	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	94.0	CHEMBL3935	Homo sapiens	Residual Activity	%	94.0
	12216752	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	94.0	CHEMBL3935	Homo sapiens	Residual Activity	%	94.0
	12216753	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12216754	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	103.0	CHEMBL3935	Homo sapiens	Residual Activity	%	103.0
	12216755	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	107.0	CHEMBL3935	Homo sapiens	Residual Activity	%	107.0
	12216756	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	104.0	CHEMBL3935	Homo sapiens	Residual Activity	%	104.0
	12216757	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	97.0	CHEMBL3935	Homo sapiens	Residual Activity	%	97.0
	12216758	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	11.0	CHEMBL3935	Homo sapiens	Residual Activity	%	11.0
	12216759	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	104.0	CHEMBL3935	Homo sapiens	Residual Activity	%	104.0
	12216760	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	92.0	CHEMBL3935	Homo sapiens	Residual Activity	%	92.0
	12216761	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	102.0	CHEMBL3935	Homo sapiens	Residual Activity	%	102.0
	12216762	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	105.0	CHEMBL3935	Homo sapiens	Residual Activity	%	105.0
	12216763	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	100.0	CHEMBL3935	Homo sapiens	Residual Activity	%	100.0
	12216764	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	98.0	CHEMBL3935	Homo sapiens	Residual Activity	%	98.0
	12216765	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	61.0	CHEMBL3935	Homo sapiens	Residual Activity	%	61.0
	12216766	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	45.0	CHEMBL3935	Homo sapiens	Residual Activity	%	45.0
	12216767	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	71.0	CHEMBL3935	Homo sapiens	Residual Activity	%	71.0
	12216768	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	85.0	CHEMBL3935	Homo sapiens	Residual Activity	%	85.0
	12216769	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	100.0	CHEMBL3935	Homo sapiens	Residual Activity	%	100.0
	12216770	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	32.0	CHEMBL3935	Homo sapiens	Residual Activity	%	32.0
	12216771	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	108.0	CHEMBL3935	Homo sapiens	Residual Activity	%	108.0
	12216772	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	102.0	CHEMBL3935	Homo sapiens	Residual Activity	%	102.0
	12216773	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12216774	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	76.0	CHEMBL3935	Homo sapiens	Residual Activity	%	76.0
	12216775	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12216776	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	79.0	CHEMBL3935	Homo sapiens	Residual Activity	%	79.0
	12216777	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	102.0	CHEMBL3935	Homo sapiens	Residual Activity	%	102.0
	12216778	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	82.0	CHEMBL3935	Homo sapiens	Residual Activity	%	82.0
	12216779	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	108.0	CHEMBL3935	Homo sapiens	Residual Activity	%	108.0
	12216780	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	106.0	CHEMBL3935	Homo sapiens	Residual Activity	%	106.0
	12216781	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	47.0	CHEMBL3935	Homo sapiens	Residual Activity	%	47.0
	12216782	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	53.0	CHEMBL3935	Homo sapiens	Residual Activity	%	53.0
	12216783	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	13.0	CHEMBL3935	Homo sapiens	Residual Activity	%	13.0
	12216784	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	66.0	CHEMBL3935	Homo sapiens	Residual Activity	%	66.0
	12216785	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	98.0	CHEMBL3935	Homo sapiens	Residual Activity	%	98.0
	12216786	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	56.0	CHEMBL3935	Homo sapiens	Residual Activity	%	56.0
	12216787	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	96.0	CHEMBL3935	Homo sapiens	Residual Activity	%	96.0
	12216788	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	102.0	CHEMBL3935	Homo sapiens	Residual Activity	%	102.0
	12216789	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	89.0	CHEMBL3935	Homo sapiens	Residual Activity	%	89.0
	12216790	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12216791	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	18.0	CHEMBL3935	Homo sapiens	Residual Activity	%	18.0
	12216792	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	5.0	CHEMBL3935	Homo sapiens	Residual Activity	%	5.0
	12216793	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	99.0	CHEMBL3935	Homo sapiens	Residual Activity	%	99.0
	12216794	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL3935	Homo sapiens	Residual Activity	%	95.0
	12216795	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	44.0	CHEMBL3935	Homo sapiens	Residual Activity	%	44.0
	12216796	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	110.0	CHEMBL3935	Homo sapiens	Residual Activity	%	110.0
	12216797	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	111.0	CHEMBL3935	Homo sapiens	Residual Activity	%	111.0
	12216798	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	101.0	CHEMBL3935	Homo sapiens	Residual Activity	%	101.0
	12216799	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	96.0	CHEMBL3935	Homo sapiens	Residual Activity	%	96.0
	12216800	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	62.0	CHEMBL3935	Homo sapiens	Residual Activity	%	62.0
	12216801	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	105.0	CHEMBL3935	Homo sapiens	Residual Activity	%	105.0
	12216802	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	64.0	CHEMBL3935	Homo sapiens	Residual Activity	%	64.0
	12216803	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	116.0	CHEMBL3935	Homo sapiens	Residual Activity	%	116.0
	12216804	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	88.0	CHEMBL3935	Homo sapiens	Residual Activity	%	88.0
	12216805	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	76.0	CHEMBL3935	Homo sapiens	Residual Activity	%	76.0
	12216806	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	115.0	CHEMBL3935	Homo sapiens	Residual Activity	%	115.0
	12216807	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	106.0	CHEMBL3935	Homo sapiens	Residual Activity	%	106.0
	12216808	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	59.0	CHEMBL3935	Homo sapiens	Residual Activity	%	59.0
	12216809	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	104.0	CHEMBL3935	Homo sapiens	Residual Activity	%	104.0
	12216810	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	69.0	CHEMBL3935	Homo sapiens	Residual Activity	%	69.0
	12216811	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	109.0	CHEMBL3935	Homo sapiens	Residual Activity	%	109.0
	12216812	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	106.0	CHEMBL3935	Homo sapiens	Residual Activity	%	106.0
	12216813	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	110.0	CHEMBL3935	Homo sapiens	Residual Activity	%	110.0
	12216814	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	18.0	CHEMBL3935	Homo sapiens	Residual Activity	%	18.0
	12216815	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	110.0	CHEMBL3935	Homo sapiens	Residual Activity	%	110.0
	12216816	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	38.0	CHEMBL3935	Homo sapiens	Residual Activity	%	38.0
	12216817	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	106.0	CHEMBL3935	Homo sapiens	Residual Activity	%	106.0
	12216818	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	3.0	CHEMBL3935	Homo sapiens	Residual Activity	%	3.0
	12216819	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	104.0	CHEMBL3935	Homo sapiens	Residual Activity	%	104.0
	12216820	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	6.0	CHEMBL3935	Homo sapiens	Residual Activity	%	6.0
	12216821	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	89.0	CHEMBL3935	Homo sapiens	Residual Activity	%	89.0
	12216822	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	96.0	CHEMBL3935	Homo sapiens	Residual Activity	%	96.0
	12216823	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	75.0	CHEMBL3935	Homo sapiens	Residual Activity	%	75.0
	12216824	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	97.0	CHEMBL3935	Homo sapiens	Residual Activity	%	97.0
	12216825	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	113.0	CHEMBL3935	Homo sapiens	Residual Activity	%	113.0
	12216826	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	115.0	CHEMBL3935	Homo sapiens	Residual Activity	%	115.0
	12216827	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	102.0	CHEMBL3935	Homo sapiens	Residual Activity	%	102.0
	12216828	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	61.0	CHEMBL3935	Homo sapiens	Residual Activity	%	61.0
	12216829	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	78.0	CHEMBL3935	Homo sapiens	Residual Activity	%	78.0
	12216830	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	83.0	CHEMBL3935	Homo sapiens	Residual Activity	%	83.0
	12216831	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	7.0	CHEMBL3935	Homo sapiens	Residual Activity	%	7.0
	12216832	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	78.0	CHEMBL3935	Homo sapiens	Residual Activity	%	78.0
	12216833	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	105.0	CHEMBL3935	Homo sapiens	Residual Activity	%	105.0
	12216834	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	96.0	CHEMBL3935	Homo sapiens	Residual Activity	%	96.0
	12216835	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	94.0	CHEMBL3935	Homo sapiens	Residual Activity	%	94.0
	12216836	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	93.0	CHEMBL3935	Homo sapiens	Residual Activity	%	93.0
	12216837	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	85.0	CHEMBL3935	Homo sapiens	Residual Activity	%	85.0
	12216838	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12216839	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	37.0	CHEMBL3935	Homo sapiens	Residual Activity	%	37.0
	12216840	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL3935	Homo sapiens	Residual Activity	%	2.0
	12216841	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	99.0	CHEMBL3935	Homo sapiens	Residual Activity	%	99.0
	12216842	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	104.0	CHEMBL3935	Homo sapiens	Residual Activity	%	104.0
	12216843	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	99.0	CHEMBL3935	Homo sapiens	Residual Activity	%	99.0
	12216844	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	95.0	CHEMBL3935	Homo sapiens	Residual Activity	%	95.0
	12216845	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12216846	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	83.0	CHEMBL3935	Homo sapiens	Residual Activity	%	83.0
	12216847	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	83.0	CHEMBL3935	Homo sapiens	Residual Activity	%	83.0
	12216848	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	76.0	CHEMBL3935	Homo sapiens	Residual Activity	%	76.0
	12216849	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	107.0	CHEMBL3935	Homo sapiens	Residual Activity	%	107.0
	12216850	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	93.0	CHEMBL3935	Homo sapiens	Residual Activity	%	93.0
	12216851	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	63.0	CHEMBL3935	Homo sapiens	Residual Activity	%	63.0
	12216852	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	89.0	CHEMBL3935	Homo sapiens	Residual Activity	%	89.0
	12216853	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	72.0	CHEMBL3935	Homo sapiens	Residual Activity	%	72.0
	12216854	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	76.0	CHEMBL3935	Homo sapiens	Residual Activity	%	76.0
	12216855	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	9.0	CHEMBL3935	Homo sapiens	Residual Activity	%	9.0
	12216856	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	83.0	CHEMBL3935	Homo sapiens	Residual Activity	%	83.0
	12216857	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	103.0	CHEMBL3935	Homo sapiens	Residual Activity	%	103.0
	12216858	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	98.0	CHEMBL3935	Homo sapiens	Residual Activity	%	98.0
	12216859	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	50.0	CHEMBL3935	Homo sapiens	Residual Activity	%	50.0
	12216860	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	22.0	CHEMBL3935	Homo sapiens	Residual Activity	%	22.0
	12216861	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	74.0	CHEMBL3935	Homo sapiens	Residual Activity	%	74.0
	12216862	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	79.0	CHEMBL3935	Homo sapiens	Residual Activity	%	79.0
	12216863	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	43.0	CHEMBL3935	Homo sapiens	Residual Activity	%	43.0
	12216864	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	79.0	CHEMBL3935	Homo sapiens	Residual Activity	%	79.0
	12216865	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	96.0	CHEMBL3935	Homo sapiens	Residual Activity	%	96.0
	12216866	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12216867	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	59.0	CHEMBL3935	Homo sapiens	Residual Activity	%	59.0
	12216868	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-2.0	CHEMBL3935	Homo sapiens	Residual Activity	%	-2.0
	12216869	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	75.0	CHEMBL3935	Homo sapiens	Residual Activity	%	75.0
	12216870	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	75.0	CHEMBL3935	Homo sapiens	Residual Activity	%	75.0
	12216871	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	9.0	CHEMBL3935	Homo sapiens	Residual Activity	%	9.0
	12219229	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	67.0	CHEMBL3935	Homo sapiens	Residual Activity	%	67.0
	12219230	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	72.0	CHEMBL3935	Homo sapiens	Residual Activity	%	72.0
	12219231	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	91.0	CHEMBL3935	Homo sapiens	Residual Activity	%	91.0
	12219232	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	72.0	CHEMBL3935	Homo sapiens	Residual Activity	%	72.0
	12219233	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	1.0	CHEMBL3935	Homo sapiens	Residual Activity	%	1.0
	12219234	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	74.0	CHEMBL3935	Homo sapiens	Residual Activity	%	74.0
	12219235	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	72.0	CHEMBL3935	Homo sapiens	Residual Activity	%	72.0
	12219236	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12219237	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	80.0	CHEMBL3935	Homo sapiens	Residual Activity	%	80.0
	12219238	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	82.0	CHEMBL3935	Homo sapiens	Residual Activity	%	82.0
	12219239	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	35.0	CHEMBL3935	Homo sapiens	Residual Activity	%	35.0
	12219240	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12219241	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	85.0	CHEMBL3935	Homo sapiens	Residual Activity	%	85.0
	12219242	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	89.0	CHEMBL3935	Homo sapiens	Residual Activity	%	89.0
	12219243	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12219244	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	80.0	CHEMBL3935	Homo sapiens	Residual Activity	%	80.0
	12219245	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	103.0	CHEMBL3935	Homo sapiens	Residual Activity	%	103.0
	12219246	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	34.0	CHEMBL3935	Homo sapiens	Residual Activity	%	34.0
	12219247	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	98.0	CHEMBL3935	Homo sapiens	Residual Activity	%	98.0
	12219248	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	97.0	CHEMBL3935	Homo sapiens	Residual Activity	%	97.0
	12219249	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	97.0	CHEMBL3935	Homo sapiens	Residual Activity	%	97.0
	12219250	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	98.0	CHEMBL3935	Homo sapiens	Residual Activity	%	98.0
	12219251	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	89.0	CHEMBL3935	Homo sapiens	Residual Activity	%	89.0
	12219252	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	113.0	CHEMBL3935	Homo sapiens	Residual Activity	%	113.0
	12219253	CHEMBL2218952	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	71.0	CHEMBL3935	Homo sapiens	Residual Activity	%	71.0
	12219254	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	99.0	CHEMBL3935	Homo sapiens	Residual Activity	%	99.0
	12219255	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	94.0	CHEMBL3935	Homo sapiens	Residual Activity	%	94.0
	12219256	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12219257	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12219258	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	64.0	CHEMBL3935	Homo sapiens	Residual Activity	%	64.0
	12219259	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	53.0	CHEMBL3935	Homo sapiens	Residual Activity	%	53.0
	12219260	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	39.0	CHEMBL3935	Homo sapiens	Residual Activity	%	39.0
	12219261	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	45.0	CHEMBL3935	Homo sapiens	Residual Activity	%	45.0
	12219262	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	42.0	CHEMBL3935	Homo sapiens	Residual Activity	%	42.0
	12219263	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	52.0	CHEMBL3935	Homo sapiens	Residual Activity	%	52.0
	12219264	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	73.0	CHEMBL3935	Homo sapiens	Residual Activity	%	73.0
	12219265	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	65.0	CHEMBL3935	Homo sapiens	Residual Activity	%	65.0
	12219266	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	80.0	CHEMBL3935	Homo sapiens	Residual Activity	%	80.0
	12219267	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	71.0	CHEMBL3935	Homo sapiens	Residual Activity	%	71.0
	12219268	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	33.0	CHEMBL3935	Homo sapiens	Residual Activity	%	33.0
	12219269	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	75.0	CHEMBL3935	Homo sapiens	Residual Activity	%	75.0
	12219270	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	93.0	CHEMBL3935	Homo sapiens	Residual Activity	%	93.0
	12219271	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12219272	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	76.0	CHEMBL3935	Homo sapiens	Residual Activity	%	76.0
	12219273	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	7.0	CHEMBL3935	Homo sapiens	Residual Activity	%	7.0
	12219274	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12219275	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	73.0	CHEMBL3935	Homo sapiens	Residual Activity	%	73.0
	12219276	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	77.0	CHEMBL3935	Homo sapiens	Residual Activity	%	77.0
	12219277	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	70.0	CHEMBL3935	Homo sapiens	Residual Activity	%	70.0
	12219278	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	74.0	CHEMBL3935	Homo sapiens	Residual Activity	%	74.0
	12219279	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	52.0	CHEMBL3935	Homo sapiens	Residual Activity	%	52.0
	12219280	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	24.0	CHEMBL3935	Homo sapiens	Residual Activity	%	24.0
	12219281	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	10.0	CHEMBL3935	Homo sapiens	Residual Activity	%	10.0
	12219282	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	25.0	CHEMBL3935	Homo sapiens	Residual Activity	%	25.0
	12219283	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	67.0	CHEMBL3935	Homo sapiens	Residual Activity	%	67.0
	12219284	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	66.0	CHEMBL3935	Homo sapiens	Residual Activity	%	66.0
	12219285	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	7.0	CHEMBL3935	Homo sapiens	Residual Activity	%	7.0
	12219286	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	86.0	CHEMBL3935	Homo sapiens	Residual Activity	%	86.0
	12219287	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12219288	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	76.0	CHEMBL3935	Homo sapiens	Residual Activity	%	76.0
	12219289	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	61.0	CHEMBL3935	Homo sapiens	Residual Activity	%	61.0
	12219290	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	62.0	CHEMBL3935	Homo sapiens	Residual Activity	%	62.0
	12219291	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	69.0	CHEMBL3935	Homo sapiens	Residual Activity	%	69.0
	12219292	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	82.0	CHEMBL3935	Homo sapiens	Residual Activity	%	82.0
	12219293	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	69.0	CHEMBL3935	Homo sapiens	Residual Activity	%	69.0
	12219294	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	92.0	CHEMBL3935	Homo sapiens	Residual Activity	%	92.0
	12219295	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12219296	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	35.0	CHEMBL3935	Homo sapiens	Residual Activity	%	35.0
	12219297	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	6.0	CHEMBL3935	Homo sapiens	Residual Activity	%	6.0
	12219298	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	1.0	CHEMBL3935	Homo sapiens	Residual Activity	%	1.0
	12219299	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	46.0	CHEMBL3935	Homo sapiens	Residual Activity	%	46.0
	12219300	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	81.0	CHEMBL3935	Homo sapiens	Residual Activity	%	81.0
	12219301	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	33.0	CHEMBL3935	Homo sapiens	Residual Activity	%	33.0
	12219302	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	42.0	CHEMBL3935	Homo sapiens	Residual Activity	%	42.0
	12219303	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	91.0	CHEMBL3935	Homo sapiens	Residual Activity	%	91.0
	12219304	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	59.0	CHEMBL3935	Homo sapiens	Residual Activity	%	59.0
	12219305	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	54.0	CHEMBL3935	Homo sapiens	Residual Activity	%	54.0
	12219306	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	-1.0	CHEMBL3935	Homo sapiens	Residual Activity	%	-1.0
	12219307	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	1.0	CHEMBL3935	Homo sapiens	Residual Activity	%	1.0
	12219308	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	76.0	CHEMBL3935	Homo sapiens	Residual Activity	%	76.0
	12219309	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	63.0	CHEMBL3935	Homo sapiens	Residual Activity	%	63.0
	12219310	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	4.0	CHEMBL3935	Homo sapiens	Residual Activity	%	4.0
	12219311	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12219312	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	67.0	CHEMBL3935	Homo sapiens	Residual Activity	%	67.0
	12219313	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	99.0	CHEMBL3935	Homo sapiens	Residual Activity	%	99.0
	12219314	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	65.0	CHEMBL3935	Homo sapiens	Residual Activity	%	65.0
	12219315	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	20.0	CHEMBL3935	Homo sapiens	Residual Activity	%	20.0
	12219316	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	80.0	CHEMBL3935	Homo sapiens	Residual Activity	%	80.0
	12219317	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	78.0	CHEMBL3935	Homo sapiens	Residual Activity	%	78.0
	12219318	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	95.0	CHEMBL3935	Homo sapiens	Residual Activity	%	95.0
	12219319	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	39.0	CHEMBL3935	Homo sapiens	Residual Activity	%	39.0
	12219320	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12219321	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	110.0	CHEMBL3935	Homo sapiens	Residual Activity	%	110.0
	12219322	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	59.0	CHEMBL3935	Homo sapiens	Residual Activity	%	59.0
	12219323	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	59.0	CHEMBL3935	Homo sapiens	Residual Activity	%	59.0
	12219324	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12219325	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	62.0	CHEMBL3935	Homo sapiens	Residual Activity	%	62.0
	12219326	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	72.0	CHEMBL3935	Homo sapiens	Residual Activity	%	72.0
	12219327	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	58.0	CHEMBL3935	Homo sapiens	Residual Activity	%	58.0
	12219328	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	47.0	CHEMBL3935	Homo sapiens	Residual Activity	%	47.0
	12219329	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	7.0	CHEMBL3935	Homo sapiens	Residual Activity	%	7.0
	12219330	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	80.0	CHEMBL3935	Homo sapiens	Residual Activity	%	80.0
	12219331	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	5.0	CHEMBL3935	Homo sapiens	Residual Activity	%	5.0
	12219332	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12219333	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL3935	Homo sapiens	Residual Activity	%	1.0
	12219334	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12219335	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	1.0	CHEMBL3935	Homo sapiens	Residual Activity	%	1.0
	12219336	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	59.0	CHEMBL3935	Homo sapiens	Residual Activity	%	59.0
	12219337	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	72.0	CHEMBL3935	Homo sapiens	Residual Activity	%	72.0
	12219338	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	52.0	CHEMBL3935	Homo sapiens	Residual Activity	%	52.0
	12219339	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	92.0	CHEMBL3935	Homo sapiens	Residual Activity	%	92.0
	12219340	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	97.0	CHEMBL3935	Homo sapiens	Residual Activity	%	97.0
	12219341	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	108.0	CHEMBL3935	Homo sapiens	Residual Activity	%	108.0
	12219342	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	92.0	CHEMBL3935	Homo sapiens	Residual Activity	%	92.0
	12219343	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	49.0	CHEMBL3935	Homo sapiens	Residual Activity	%	49.0
	12219344	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	75.0	CHEMBL3935	Homo sapiens	Residual Activity	%	75.0
	12219345	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	66.0	CHEMBL3935	Homo sapiens	Residual Activity	%	66.0
	12219346	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	4.0	CHEMBL3935	Homo sapiens	Residual Activity	%	4.0
	12219347	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	91.0	CHEMBL3935	Homo sapiens	Residual Activity	%	91.0
	12219348	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	97.0	CHEMBL3935	Homo sapiens	Residual Activity	%	97.0
	12219349	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	59.0	CHEMBL3935	Homo sapiens	Residual Activity	%	59.0
	12219350	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	91.0	CHEMBL3935	Homo sapiens	Residual Activity	%	91.0
	12219351	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12219352	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	85.0	CHEMBL3935	Homo sapiens	Residual Activity	%	85.0
	12219353	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12219354	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	12.0	CHEMBL3935	Homo sapiens	Residual Activity	%	12.0
	12219355	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL3935	Homo sapiens	Residual Activity	%	1.0
	12219356	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	94.0	CHEMBL3935	Homo sapiens	Residual Activity	%	94.0
	12219357	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	100.0	CHEMBL3935	Homo sapiens	Residual Activity	%	100.0
	12219358	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12219359	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	89.0	CHEMBL3935	Homo sapiens	Residual Activity	%	89.0
	12219360	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	78.0	CHEMBL3935	Homo sapiens	Residual Activity	%	78.0
	12219361	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	72.0	CHEMBL3935	Homo sapiens	Residual Activity	%	72.0
	12219362	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12219363	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	71.0	CHEMBL3935	Homo sapiens	Residual Activity	%	71.0
	12219364	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	92.0	CHEMBL3935	Homo sapiens	Residual Activity	%	92.0
	12219365	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	81.0	CHEMBL3935	Homo sapiens	Residual Activity	%	81.0
	12219366	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	22.0	CHEMBL3935	Homo sapiens	Residual Activity	%	22.0
	12219367	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	84.0	CHEMBL3935	Homo sapiens	Residual Activity	%	84.0
	12219368	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	79.0	CHEMBL3935	Homo sapiens	Residual Activity	%	79.0
	12219369	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	77.0	CHEMBL3935	Homo sapiens	Residual Activity	%	77.0
	12219370	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	3.0	CHEMBL3935	Homo sapiens	Residual Activity	%	3.0
	12219371	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	88.0	CHEMBL3935	Homo sapiens	Residual Activity	%	88.0
	12219372	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	78.0	CHEMBL3935	Homo sapiens	Residual Activity	%	78.0
	12219373	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	95.0	CHEMBL3935	Homo sapiens	Residual Activity	%	95.0
	12219374	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	49.0	CHEMBL3935	Homo sapiens	Residual Activity	%	49.0
	12219375	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	3.0	CHEMBL3935	Homo sapiens	Residual Activity	%	3.0
	12219376	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	52.0	CHEMBL3935	Homo sapiens	Residual Activity	%	52.0
	12219377	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	74.0	CHEMBL3935	Homo sapiens	Residual Activity	%	74.0
	12219378	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	30.0	CHEMBL3935	Homo sapiens	Residual Activity	%	30.0
	12219379	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	83.0	CHEMBL3935	Homo sapiens	Residual Activity	%	83.0
	12219380	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	78.0	CHEMBL3935	Homo sapiens	Residual Activity	%	78.0
	12219381	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	92.0	CHEMBL3935	Homo sapiens	Residual Activity	%	92.0
	12219382	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	54.0	CHEMBL3935	Homo sapiens	Residual Activity	%	54.0
	12219383	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL3935	Homo sapiens	Residual Activity	%	0.0
	12219384	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	85.0	CHEMBL3935	Homo sapiens	Residual Activity	%	85.0
	12219385	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	78.0	CHEMBL3935	Homo sapiens	Residual Activity	%	78.0
	12219386	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	4.0	CHEMBL3935	Homo sapiens	Residual Activity	%	4.0
	12219387	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	62.0	CHEMBL3935	Homo sapiens	Residual Activity	%	62.0
	12219388	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	20.0	CHEMBL3935	Homo sapiens	Residual Activity	%	20.0
	12219389	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	52.0	CHEMBL3935	Homo sapiens	Residual Activity	%	52.0
	12219390	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	30.0	CHEMBL3935	Homo sapiens	Residual Activity	%	30.0
	12219391	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	2.0	CHEMBL3935	Homo sapiens	Residual Activity	%	2.0
	12219392	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	76.0	CHEMBL3935	Homo sapiens	Residual Activity	%	76.0
	12219393	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	58.0	CHEMBL3935	Homo sapiens	Residual Activity	%	58.0
	12219394	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	83.0	CHEMBL3935	Homo sapiens	Residual Activity	%	83.0
	12219395	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	22.0	CHEMBL3935	Homo sapiens	Residual Activity	%	22.0
	12219396	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	43.0	CHEMBL3935	Homo sapiens	Residual Activity	%	43.0
	12219397	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	4.0	CHEMBL3935	Homo sapiens	Residual Activity	%	4.0
	12219398	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12219399	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	90.0	CHEMBL3935	Homo sapiens	Residual Activity	%	90.0
	12219400	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	82.0	CHEMBL3935	Homo sapiens	Residual Activity	%	82.0
	12219401	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	86.0	CHEMBL3935	Homo sapiens	Residual Activity	%	86.0
	12219402	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	43.0	CHEMBL3935	Homo sapiens	Residual Activity	%	43.0
	12219403	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	83.0	CHEMBL3935	Homo sapiens	Residual Activity	%	83.0
	12219404	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	4.0	CHEMBL3935	Homo sapiens	Residual Activity	%	4.0
	12219405	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	78.0	CHEMBL3935	Homo sapiens	Residual Activity	%	78.0
	12219406	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	88.0	CHEMBL3935	Homo sapiens	Residual Activity	%	88.0
	12219407	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	88.0	CHEMBL3935	Homo sapiens	Residual Activity	%	88.0
	12219408	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	97.0	CHEMBL3935	Homo sapiens	Residual Activity	%	97.0
	12219409	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	87.0	CHEMBL3935	Homo sapiens	Residual Activity	%	87.0
	12219410	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	95.0	CHEMBL3935	Homo sapiens	Residual Activity	%	95.0
	12219411	CHEMBL2218953	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	54.0	CHEMBL3935	Homo sapiens	Residual Activity	%	54.0
	12626686	CHEMBL2317135	Inhibition of aurora C (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL3935	Homo sapiens	INH	%	80.0
	12728894	CHEMBL2350227	Inhibition of Aurora C (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	83.0	CHEMBL3935	Homo sapiens	Activity	%	83.0
	12730036	CHEMBL2353911	Inhibition of Aurora C (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	95.0	CHEMBL3935	Homo sapiens	Activity	%	95.0
	12730930	CHEMBL2350103	Inhibition of Aurora C (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	87.0	CHEMBL3935	Homo sapiens	Activity	%	87.0
	12731173	CHEMBL2350227	Inhibition of Aurora C (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	92.0	CHEMBL3935	Homo sapiens	Activity	%	92.0
	13301918	CHEMBL2383378	Inhibition of human AURKC at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2n[nH]c3cc(-c4cnn(C)c4)c(NC4CCCCC4)cc23)c1		CHEMBL2380587	>	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	13301919	CHEMBL2383378	Inhibition of human AURKC at 1 uM relative to control	B	Cn1cc(-c2cc3[nH]nc(-c4cccc(S(N)(=O)=O)c4)c3cc2NC2CCCCC2)cn1		CHEMBL2380586	>	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
Not Determined	13327702	CHEMBL2389848	Inhibition of AURKC (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
	13327703	CHEMBL2389848	Inhibition of AURKC (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	16.0	CHEMBL3935	Homo sapiens	INH	%	16.0
	13343474	CHEMBL2396195	Inhibition of aurora C (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	13359788	CHEMBL2400109	Inhibition of Aurora kinase C (unknown origin) at 1 uM relative to control	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657	>	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	13375942	CHEMBL2405952	Inhibition of AURKC (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL3935	Homo sapiens	INH	%	1.0
	13419559	CHEMBL2423808	Inhibition of AURC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	61.0	CHEMBL3935	Homo sapiens	INH	%	61.0
	13419560	CHEMBL2423808	Inhibition of AURC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	46.0	CHEMBL3935	Homo sapiens	INH	%	46.0
	13419561	CHEMBL2423808	Inhibition of AURC (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	54.0	CHEMBL3935	Homo sapiens	INH	%	54.0
	13442403	CHEMBL2428025	Competitive binding affinity to AURKC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	13445538	CHEMBL2428025	Competitive binding affinity to AURKC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	96.0	CHEMBL3935	Homo sapiens	INH	%	96.0
	13448593	CHEMBL2428025	Competitive binding affinity to AURKC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	13448729	CHEMBL2428025	Competitive binding affinity to AURKC (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	13451524	CHEMBL2428025	Competitive binding affinity to AURKC (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	97.0	CHEMBL3935	Homo sapiens	INH	%	97.0
	13454709	CHEMBL2428025	Competitive binding affinity to AURKC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	13476351	CHEMBL2439769	Inhibition of wild type human Aurora kinase C kinase by high throughput ATP-[33P] radiolabeled assay	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	IC50	nM	290.0	CHEMBL3935	Homo sapiens	IC50	nM	290.0
	13476377	CHEMBL2438993	Inhibition of human wild type Aurora kinase C at 1 uM by qPCR analysis relative to control	B	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O		CHEMBL290352	>	Inhibition	%	99.0	CHEMBL3935	Homo sapiens	INH	%	99.0
	13872239	CHEMBL3102545	Inhibition of Aurora-C (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	76.0	CHEMBL3935	Homo sapiens	Activity	%	76.0
	13872269	CHEMBL3100470	Inhibition of Aurora-C (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	89.0	CHEMBL3935	Homo sapiens	Activity	%	89.0
	13954736	CHEMBL3130942	Inhibition of human Aurora-C assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	77.0	CHEMBL3935	Homo sapiens	Activity	%	77.0
	13954738	CHEMBL3130942	Inhibition of human Aurora-C assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	76.0	CHEMBL3935	Homo sapiens	Activity	%	76.0
	13954739	CHEMBL3130942	Inhibition of human Aurora-C assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	76.0	CHEMBL3935	Homo sapiens	Activity	%	76.0
	13966014	CHEMBL3136065	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	96.0	CHEMBL3935	Homo sapiens	INH	%	96.0
	13973289	CHEMBL3136763	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	1.0	CHEMBL3935	Homo sapiens	INH	%	1.0
	13973395	CHEMBL3134649	Inhibition of aurora-C (unknown origin) using tetra(LRRWSLG) as substrate after 60 mins by scintillation counting	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	=	IC50	nM	259.0	CHEMBL3935	Homo sapiens	IC50	nM	259.0
	13974007	CHEMBL3135907	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	7.5	CHEMBL3935	Homo sapiens	INH	%	7.5
	13974098	CHEMBL3135609	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	11.5	CHEMBL3935	Homo sapiens	INH	%	11.5
	13974189	CHEMBL3137129	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	99.0	CHEMBL3935	Homo sapiens	INH	%	99.0
	13974280	CHEMBL3136258	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	95.5	CHEMBL3935	Homo sapiens	INH	%	95.5
	13975018	CHEMBL3135978	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	7.0	CHEMBL3935	Homo sapiens	INH	%	7.0
	13975109	CHEMBL3135705	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL3935	Homo sapiens	INH	%	0.0
	13975200	CHEMBL3135789	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	13.5	CHEMBL3935	Homo sapiens	INH	%	13.5
	13975843	CHEMBL3134766	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	34.0	CHEMBL3935	Homo sapiens	INH	%	34.0
	13975936	CHEMBL3136873	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	73.5	CHEMBL3935	Homo sapiens	INH	%	73.5
	13976027	CHEMBL3135227	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	87.5	CHEMBL3935	Homo sapiens	INH	%	87.5
	13976118	CHEMBL3136789	Inhibition of human full length AurC expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	73.0	CHEMBL3935	Homo sapiens	INH	%	73.0
	14600188	CHEMBL3243851	Inhibition of N-terminal His-6-tagged recombinant Aurora 3 (1 to 309) (unknown origin) expressed in baculovirus expression system by radiometric assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	14984397	CHEMBL3384394	Inhibition of AURKC (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	10.0	CHEMBL3935	Homo sapiens	INH	%	10.0
	14984463	CHEMBL3381884	Inhibition of AURKC (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	27.0	CHEMBL3935	Homo sapiens	INH	%	27.0
	14992861	CHEMBL3372228	Inhibition of recombinant AURKC (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	4750.0	CHEMBL3935	Homo sapiens	IC50	uM	4.75
	15022483	CHEMBL3380447	Inhibition of Aurora C (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3329652	=	Inhibition	%	17.0	CHEMBL3935	Homo sapiens	INH	%	17.0
	15022484	CHEMBL3380447	Inhibition of Aurora C (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	Inhibition	%	20.0	CHEMBL3935	Homo sapiens	INH	%	20.0
	15025258	CHEMBL3362103	Inhibition of Aurora C (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C(CC(=O)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1)Nc1ccc(F)cc1		CHEMBL3322563	=	IC50	nM	67.2	CHEMBL3935	Homo sapiens	IC50	nM	67.2
	15025259	CHEMBL3362103	Inhibition of Aurora C (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)O)c2C)cc1		CHEMBL3322565	=	IC50	nM	153.5	CHEMBL3935	Homo sapiens	IC50	nM	153.5
	15025260	CHEMBL3362104	Inhibition of Aurora C (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3322564	=	Inhibition	%	31.0	CHEMBL3935	Homo sapiens	INH	%	31.0
	15025261	CHEMBL3362104	Inhibition of Aurora C (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)cc1		CHEMBL3322566	=	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	15025262	CHEMBL3362104	Inhibition of Aurora C (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322567	=	Inhibition	%	18.0	CHEMBL3935	Homo sapiens	INH	%	18.0
	15025263	CHEMBL3362104	Inhibition of Aurora C (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)C2(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)CC2)cc1		CHEMBL3322568	=	Inhibition	%	14.0	CHEMBL3935	Homo sapiens	INH	%	14.0
	15025420	CHEMBL3362104	Inhibition of Aurora C (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590	=	Inhibition	%	16.1	CHEMBL3935	Homo sapiens	INH	%	16.1
Active	15100338	CHEMBL3389103	Inhibition of Aurora C kinase phosphorylation in human HT-29 cells at 10 uM incubated for 15 to 120 mins by Western blotting method	B	COc1c2c(cc3oc(C)cc(=O)c13)OC(C(C)(C)O[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O)C2		CHEMBL2059296		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
	15104935	CHEMBL3386797	Inhibition of AURKC (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	14.0	CHEMBL3935	Homo sapiens	Activity	%	14.0
	15104936	CHEMBL3386797	Inhibition of AURKC (unknown origin) assessed as residual enzyme activity at 10 uM	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337845	=	Activity	%	22.0	CHEMBL3935	Homo sapiens	Activity	%	22.0
	15152324	CHEMBL3396727	Inhibition of poly-histidine tagged full length recombinant aurora C (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)[C@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393498	=	IC50	nM	3.0	CHEMBL3935	Homo sapiens	IC50	nM	3.0
	15152446	CHEMBL3395869	Inhibition of aurora C (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	4.6	CHEMBL3935	Homo sapiens	IC50	nM	4.6
	15152447	CHEMBL3395869	Inhibition of aurora C (unknown origin)	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	61.0	CHEMBL3935	Homo sapiens	IC50	nM	61.0
	15649111	CHEMBL3595096	Inhibition of AurC (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	>	IC50	nM	1000.0	CHEMBL3935	Homo sapiens	IC50	nM	1000.0
	15650146	CHEMBL3595412	Inhibition of human AURKC at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	45.0	CHEMBL3935	Homo sapiens	INH	%	45.0
	15756104	CHEMBL3632162	Inhibition of Aurora C (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	11.02	CHEMBL3935	Homo sapiens	INH	%	11.02
	15757699	CHEMBL3632162	Inhibition of Aurora C (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	15.75	CHEMBL3935	Homo sapiens	INH	%	15.75
	15757995	CHEMBL3632162	Inhibition of Aurora C (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	3.77	CHEMBL3935	Homo sapiens	INH	%	3.77
	16431735	CHEMBL3748627	Inhibition of human Aurora C using [H-LRRASLG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3935	Homo sapiens	IC50	uM	10.0
	16450766	CHEMBL3762152	Inhibition of Aurora C (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	1.2	CHEMBL3935	Homo sapiens	INH	%	1.2
	16495338	CHEMBL3776885	Inhibition of N-terminal His6-tagged recombinant human AURKC expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-4.0	CHEMBL3935	Homo sapiens	Activity	%	-4.0
	16501358	CHEMBL3778047	Inhibition of full length human N-terminal GST-HIS6-tagged Aurora C expressed in sf9 cells by flashplate based radiometric 33pan-quinase assay	B	CS(=O)(=O)O.Cc1oc2c(O)c3c(c(O)c2c1C(=O)N1CC[C@H](N)C1)C(=O)c1ccccc1C3=O		CHEMBL3775181	<	IC50	nM	5000.0	CHEMBL3935	Homo sapiens	IC50	uM	5.0
	16508107	CHEMBL3776885	Inhibition of N-terminal His6-tagged recombinant human AURKC expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	3.0	CHEMBL3935	Homo sapiens	Activity	%	3.0
	16509084	CHEMBL3776885	Inhibition of N-terminal His6-tagged recombinant human AURKC expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-10.0	CHEMBL3935	Homo sapiens	Activity	%	-10.0
Active	16581015	CHEMBL3802147	Inhibition of human Aurora-C by radiometric assay	B	CC(C)c1nn(C)cc1-c1nc2cc(Br)cnc2[nH]1		CHEMBL3613594		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
	16593474	CHEMBL3812158	Inhibition of full length His-tagged human recombinant Aurora C expressed in baculovirus using Fluorescein-CREBtide as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL3935	Homo sapiens	INH	%	40.0
	16611904	CHEMBL3816638	Inhibition of AURKC (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-15.0	CHEMBL3935	Homo sapiens	Activity	%	-15.0
	16611905	CHEMBL3816638	Inhibition of AURKC (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-3.0	CHEMBL3935	Homo sapiens	Activity	%	-3.0
	16613774	CHEMBL3817210	Inhibition of human Aurora C at 1 uM using [H-LRRASLG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-1.0	CHEMBL3935	Homo sapiens	INH	%	-1.0
	16618277	CHEMBL3817008	Inhibition of full length recombinant human GST-tagged AURKC expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	16763140	CHEMBL3862729	Binding affinity to human Aurora C kinase expressed in Escherichia coli BL21 cells incubated for 1 hr by active site directed binding competition assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	=	Kd	nM	10.8	CHEMBL3935	Homo sapiens	Kd	nM	10.8
	16815385	CHEMBL3871597	Inhibition of recombinant N-terminal His6-tagged Aurora C (1 to 309 residues) (unknown origin) expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	16815388	CHEMBL3871600	Inhibition of human recombinant full-length N-terminal GST-tagged Aurora C (1 to 275 end residues) expressed in baculovirus expression system using GLRRASLG-NH2 as substrate after 20 mins in presence of [gamma-33P]-ATP by liquid scintillation counting	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	IC50	nM	12.0	CHEMBL3935	Homo sapiens	IC50	nM	12.0
	16815450	CHEMBL3871611	Inhibition of human recombinant full-length GST-tagged Aurora C expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	94.0	CHEMBL3935	Homo sapiens	INH	%	94.0
Active	18078260	CHEMBL4016721	Inhibition of human N-terminal GST-tagged Aurora B (M1 to S27 residues) expressed in sf9 cells at 1 uM using CDC25C-derived peptide as substrate by filter binding assay	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCC(O)CO		CHEMBL1276317		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
Not Active	18078261	CHEMBL4016721	Inhibition of human N-terminal GST-tagged Aurora B (M1 to S27 residues) expressed in sf9 cells at 1 uM using CDC25C-derived peptide as substrate by filter binding assay	B	CN1CCN(CCO/N=C2C(=C3/C(=O)Nc4ccccc43)/Nc3ccccc3/2)CC1.Cl		CHEMBL4084775		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
Active	18078262	CHEMBL4016721	Inhibition of human N-terminal GST-tagged Aurora B (M1 to S27 residues) expressed in sf9 cells at 1 uM using CDC25C-derived peptide as substrate by filter binding assay	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
Active	18078263	CHEMBL4016721	Inhibition of human N-terminal GST-tagged Aurora B (M1 to S27 residues) expressed in sf9 cells at 1 uM using CDC25C-derived peptide as substrate by filter binding assay	B	Cc1ccc2c(c1)NC(=O)/C2=C1\Nc2ccccc2\C1=N/O		CHEMBL4067175		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
	18114474	CHEMBL4025020	Inhibition of wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	18153132	CHEMBL4034266	Inhibition of AUR C ATP binding site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	10.3	CHEMBL3935	Homo sapiens	INH	%	10.3
	18203410	CHEMBL4043831	Inhibition of wild-type human full length AURKC (M1 to S275 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	18253287	CHEMBL4054927	Inhibition of wild-type human full length AURC (M1 to S275 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	42.0	CHEMBL3935	Homo sapiens	Activity	%	42.0
	18253288	CHEMBL4054927	Inhibition of wild-type human full length AURC (M1 to S275 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	82.0	CHEMBL3935	Homo sapiens	Activity	%	82.0
	18265806	CHEMBL4057256	Inhibition of AurC (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.0	CHEMBL3935	Homo sapiens	INH	%	-1.0
	18266004	CHEMBL4057454	Inhibition of AurC (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-3.3	CHEMBL3935	Homo sapiens	INH	%	-3.3
	18274767	CHEMBL4118301	Inhibition of AurC in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled GKFGNVYLAR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	95.1	CHEMBL3935	Homo sapiens	INH	%	95.1
	18274768	CHEMBL4118301	Inhibition of AurC in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled GKFGNVYLAR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	57.9	CHEMBL3935	Homo sapiens	INH	%	57.9
	18274769	CHEMBL4118301	Inhibition of AurC in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled GKFGNVYLAR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	55.7	CHEMBL3935	Homo sapiens	INH	%	55.7
	18282803	CHEMBL4120388	Inhibition of AurC (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.0	CHEMBL3935	Homo sapiens	INH	%	-1.0
	18283030	CHEMBL4120615	Inhibition of AurC (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1	Outside typical range	CHEMBL4125807	=	Inhibition	%	-12.7	CHEMBL3935	Homo sapiens	INH	%	-12.7
	18283196	CHEMBL4120781	Inhibition of AurC (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	6.3	CHEMBL3935	Homo sapiens	INH	%	6.3
	18379255	CHEMBL4145353	Inhibition of wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system at 10 uM by ATP-site competition binding assay based KinomeScan assay relative to control	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1N		CHEMBL4172550	>	Inhibition	%	90.0	CHEMBL3935	Homo sapiens	INH	%	90.0
	18440086	CHEMBL4156910	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	92.0	CHEMBL3935	Homo sapiens	Activity	%	92.0
	18484474	CHEMBL4185636	Inhibition of recombinant full length GST-tagged human Aurora C expressed in baculovirus expression system by Z'LYTE assay	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	IC50	nM	53.0	CHEMBL3935	Homo sapiens	IC50	nM	53.0
	18484526	CHEMBL4185689	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	1.3	CHEMBL3935	Homo sapiens	Activity	%	1.3
	18484952	CHEMBL4185636	Inhibition of recombinant full length GST-tagged human Aurora C expressed in baculovirus expression system by Z'LYTE assay	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)[C@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393498	=	IC50	nM	91.0	CHEMBL3935	Homo sapiens	IC50	nM	91.0
	18485095	CHEMBL4185689	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	49.0	CHEMBL3935	Homo sapiens	Activity	%	49.0
	18485147	CHEMBL4185636	Inhibition of recombinant full length GST-tagged human Aurora C expressed in baculovirus expression system by Z'LYTE assay	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	IC50	nM	63.0	CHEMBL3935	Homo sapiens	IC50	nM	63.0
	18507891	CHEMBL4190876	Inhibition of recombinant human Aurora-C (35 to end residues) at 1 uM using AKRRRLSSLRA as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	Outside typical range	CHEMBL4207014	=	Inhibition	%	-24.0	CHEMBL3935	Homo sapiens	INH	%	-24.0
	18653759	CHEMBL4230024	Inhibition of AURORA-C (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	33.0	CHEMBL3935	Homo sapiens	INH	%	33.0
	18653760	CHEMBL4230024	Inhibition of AURORA-C (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-2.0	CHEMBL3935	Homo sapiens	INH	%	-2.0
	18655631	CHEMBL4230589	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	97.0	CHEMBL3935	Homo sapiens	Activity	%	97.0
	18665491	CHEMBL4233291	Inhibition of AURC (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	5000.0	CHEMBL3935	Homo sapiens	IC50	nM	5000.0
	18665561	CHEMBL4233291	Inhibition of AURC (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	2000.0	CHEMBL3935	Homo sapiens	IC50	nM	2000.0
	18674547	CHEMBL4235316	Inhibition of AurC (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL3935	Homo sapiens	Ki	nM	10000.0
	18674548	CHEMBL4235316	Inhibition of AurC (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	1000.0	CHEMBL3935	Homo sapiens	Ki	nM	1000.0
	18674549	CHEMBL4235316	Inhibition of AurC (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	1000.0	CHEMBL3935	Homo sapiens	Ki	nM	1000.0
	18751067	CHEMBL4263738	Inhibition of AURORA-C (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	10.0	CHEMBL3935	Homo sapiens	INH	%	10.0
	18751725	CHEMBL4264178	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	18761207	CHEMBL4266268	Inhibition of Aurora C kinase (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	4.6	CHEMBL3935	Homo sapiens	IC50	nM	4.6
	18761208	CHEMBL4266268	Inhibition of Aurora C kinase (unknown origin)	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	61.0	CHEMBL3935	Homo sapiens	IC50	nM	61.0
	18761209	CHEMBL4266268	Inhibition of Aurora C kinase (unknown origin)	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	IC50	nM	1.0	CHEMBL3935	Homo sapiens	IC50	nM	1.0
	18761210	CHEMBL4266268	Inhibition of Aurora C kinase (unknown origin)	B	O=C(Nc1cccc(Cl)c1)NC1NC=C(CCNc2ncnc3sccc23)S1		CHEMBL4277690	=	IC50	nM	3.0	CHEMBL3935	Homo sapiens	IC50	nM	3.0
	18761211	CHEMBL4266268	Inhibition of Aurora C kinase (unknown origin)	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	6.5	CHEMBL3935	Homo sapiens	IC50	nM	6.5
	18761283	CHEMBL4266348	Inhibition of GST-tagged recombinant human Aurora C kinase expressed in High5 cells using Auroratide substrate and [gamma33-ATP] by scintillation proximity assay	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	120.0	CHEMBL3935	Homo sapiens	IC50	nM	120.0
	18857849	CHEMBL4307695	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	92.0	CHEMBL3935	Homo sapiens	Activity	%	92.0
	18878205	CHEMBL4311522	Inhibition of recombinant N-terminal His6-tagged Aurora C (1 to 309 residues) (unknown origin) expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	18892757	CHEMBL4314653	Inhibition of recombinant human AURKC (35 to end residues) assessed as residual activity at 10 uM using AKRRRLSSLRA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.5	CHEMBL3935	Homo sapiens	Activity	%	105.5
	18937721	CHEMBL4327590	Inhibition of human Aurora C assessed as residual activity at 1 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	87.18	CHEMBL3935	Homo sapiens	Activity	%	87.18
	18937722	CHEMBL4327590	Inhibition of human Aurora C assessed as residual activity at 1 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	95.79	CHEMBL3935	Homo sapiens	Activity	%	95.79
	18938431	CHEMBL4327951	Inhibition of human Aurora C assessed as residual activity at 100 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3935	Homo sapiens	Activity	%	65.0
	18938803	CHEMBL4328315	Inhibition of human Aurora C using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.42	CHEMBL3935	Homo sapiens	IC50	10'-9M	2.42
	18958676	CHEMBL4333287	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	18964078	CHEMBL4334973	Inhibition of recombinant human Aurora C (35 to end residues) assessed as residual activity at 1 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	109.0	CHEMBL3935	Homo sapiens	Activity	%	109.0
	18964079	CHEMBL4334973	Inhibition of recombinant human Aurora C (35 to end residues) assessed as residual activity at 1 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	104.0	CHEMBL3935	Homo sapiens	Activity	%	104.0
	18971791	CHEMBL4336801	Inhibition of recombinant human Aurora C (35 to end residues) assessed as residual activity at 10 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	68.0	CHEMBL3935	Homo sapiens	Activity	%	68.0
Not Active	19039891	CHEMBL4351750	Inhibition of recombinant human AURKC (35 to end residues) at 10 uM using AKRRRLSSLRA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
Active	19041016	CHEMBL4352277	Inhibition of human Aurora C at 10 uM using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
	19059466	CHEMBL4357767	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	98.0	CHEMBL3935	Homo sapiens	Activity	%	98.0
	19090039	CHEMBL4365613	Inhibition of wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	89.0	CHEMBL3935	Homo sapiens	Activity	%	89.0
	19091819	CHEMBL4366293	Inhibition of human Aurora C at 100 nM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	10.13	CHEMBL3935	Homo sapiens	INH	%	10.13
	19133362	CHEMBL4375350	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system measured after 1 hr by Kinomescan method	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812	=	Kd	nM	289.0	CHEMBL3935	Homo sapiens	Kd	nM	289.0
	19144620	CHEMBL4377636	Inhibition of recombinant human AURKC (35 to end residues) at 1 uM using AKRRRLSSLRA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	72.0	CHEMBL3935	Homo sapiens	INH	%	72.0
	19147749	CHEMBL4379145	Inhibition of human recombinant AURORA-C (35 to end residues) using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3935	Homo sapiens	IC50	uM	10.0
	19159294	CHEMBL4382398	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	8.2	CHEMBL3935	Homo sapiens	Activity	%	8.2
	19191231	CHEMBL4389594	Inhibition of wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	33.0	CHEMBL3935	Homo sapiens	INH	%	33.0
	19191713	CHEMBL4389117	Inhibition of wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	4.3	CHEMBL3935	Homo sapiens	INH	%	4.3
	19200002	CHEMBL4391220	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	13.0	CHEMBL3935	Homo sapiens	Activity	%	13.0
	19266316	CHEMBL4405266	Inhibition of wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	19275935	CHEMBL4407938	Inhibition of recombinant human Aurora-C (35 to end residues) at 1 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	9.0	CHEMBL3935	Homo sapiens	INH	%	9.0
Tde	19411837	CHEMBL4427794	Inhibition of aurora C phosphorylation at Thr-198 in human HCT116 cells at 20 uM by Western blot analysis	B	COc1ccc(C2CC(c3ccc4ccccc4c3O)=NN2C(=S)Nc2cccc(OC)c2)cc1		CHEMBL4514298		Inhibition	%		CHEMBL3935	Homo sapiens	INH		
	19432883	CHEMBL4429539	Inhibition of AurC (unknown origin) at 1 uM	B	Cc1nccc(Nc2cc(NC3CCN(c4ccc(C#N)cc4)CC3)c(C(N)=O)cn2)n1		CHEMBL4463436	=	Inhibition	%	28.0	CHEMBL3935	Homo sapiens	INH	%	28.0
	20600466	CHEMBL4603283	Inhibition of recombinant full length GST-tagged human AURKC expressed in baculovirus expression system using Ser/Thr-19 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3935	Homo sapiens	IC50	uM	100.0
	20632004	CHEMBL4610948	Inhibition of N-terminal His6-tagged Aurora C (1 to 309 residues) (unknown origin) expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	4.6	CHEMBL3935	Homo sapiens	Ki	nM	4.6
	20632007	CHEMBL4610951	Inhibition of recombinant full-length His-tagged human Aurora C expressed in baculovirus expression system	B	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1		CHEMBL188343	=	IC50	nM	400.0	CHEMBL3935	Homo sapiens	IC50	nM	400.0
	22408955	CHEMBL4671028	Inhibition of AuroraC (unknown origin)	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	7.0	CHEMBL3935	Homo sapiens	IC50	nM	7.0
	22423121	CHEMBL4674134	Inhibition of human Aurora C using [H-LRRASLG] as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL3935	Homo sapiens	INH	%	80.0
	22423819	CHEMBL4674485	Inhibition of human Aurora C using [H-LRRASLG] as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	98.83	CHEMBL3935	Homo sapiens	Activity	%	98.83
	22423820	CHEMBL4674485	Inhibition of human Aurora C using [H-LRRASLG] as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	60.92	CHEMBL3935	Homo sapiens	Activity	%	60.92
	22843494	CHEMBL4720491	Inhibition of human Aurora C assessed as residual activity using [H-LRRASLG] as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	95.16	CHEMBL3935	Homo sapiens	Activity	%	95.16
	22843843	CHEMBL4720829	Inhibition of human Aurora C using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.92	CHEMBL3935	Homo sapiens	IC50	10^-9M	1.92
	22844625	CHEMBL4721300	Inhibition of wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	97.32	CHEMBL3935	Homo sapiens	Activity	%	97.32
	22952759	CHEMBL4766696	Inhibition of recombinant human Aurora C (35 to end residues) assessed as residual activity at 10 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	13.0	CHEMBL3935	Homo sapiens	Activity	%	13.0
	22979766	CHEMBL4772648	Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	=	Kd	nM	570.0	CHEMBL3935	Homo sapiens	Kd	nM	570.0
	22979800	CHEMBL4772682	Inhibition of wild-type human full length AURKC (M1 to S275 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	>	Activity	%	90.0	CHEMBL3935	Homo sapiens	Activity	%	90.0
	23120199	CHEMBL4804347	Inhibition of AURC in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	17700.0	CHEMBL3935	Homo sapiens	IC50	uM	17.7
	23120200	CHEMBL4804347	Inhibition of AURC in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	21400.0	CHEMBL3935	Homo sapiens	IC50	uM	21.4
	23120201	CHEMBL4804347	Inhibition of AURC in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	17800.0	CHEMBL3935	Homo sapiens	IC50	uM	17.8
	23120202	CHEMBL4804347	Inhibition of AURC in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	53200.0	CHEMBL3935	Homo sapiens	IC50	uM	53.2
	23120203	CHEMBL4804347	Inhibition of AURC in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	42900.0	CHEMBL3935	Homo sapiens	IC50	uM	42.9
	23120204	CHEMBL4804347	Inhibition of AURC in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	66200.0	CHEMBL3935	Homo sapiens	IC50	uM	66.2
	23121243	CHEMBL4804529	Inhibition of AURC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3935	Homo sapiens	INH	%	0.0
	23121244	CHEMBL4804529	Inhibition of AURC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL3935	Homo sapiens	INH	%	0.0
	23121245	CHEMBL4804529	Inhibition of AURC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL3935	Homo sapiens	INH	%	0.0
	23121246	CHEMBL4804529	Inhibition of AURC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	23121247	CHEMBL4804529	Inhibition of AURC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	35.0	CHEMBL3935	Homo sapiens	INH	%	35.0
	23121248	CHEMBL4804529	Inhibition of AURC in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	50.0	CHEMBL3935	Homo sapiens	INH	%	50.0
	23122452	CHEMBL4804803	Inhibition of human AURKC assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	23123147	CHEMBL4805391	Inhibition of human AURKC assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	23123740	CHEMBL4805984	Inhibition of DNA-tagged human AURKC assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	94.0	CHEMBL3935	Homo sapiens	Activity	%	94.0
	23124384	CHEMBL4806408	Inhibition of human AURKC assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	23124385	CHEMBL4806408	Inhibition of human AURKC assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3935	Homo sapiens	Activity	%	100.0
	23127828	CHEMBL4807751	Inhibition of AuroraC (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL3935	Homo sapiens	Activity	%	75.0
	23127829	CHEMBL4807751	Inhibition of AuroraC (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3935	Homo sapiens	Activity	%	75.0
	23127830	CHEMBL4807751	Inhibition of AuroraC (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3935	Homo sapiens	Activity	%	75.0
Not Active	23317287	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	80.0	CHEMBL3935	Homo sapiens	% Control	%	80.0
Not Active	23317755	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23318428	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23318905	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	90.0	CHEMBL3935	Homo sapiens	% Control	%	90.0
Not Active	23319545	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23320017	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23320695	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23321163	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23321793	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	91.0	CHEMBL3935	Homo sapiens	% Control	%	91.0
Not Active	23322261	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	94.0	CHEMBL3935	Homo sapiens	% Control	%	94.0
Not Active	23322950	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23323418	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23324272	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23324907	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	79.0	CHEMBL3935	Homo sapiens	% Control	%	79.0
Not Active	23325375	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23326022	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23326490	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	63.0	CHEMBL3935	Homo sapiens	% Control	%	63.0
Not Active	23327190	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	82.0	CHEMBL3935	Homo sapiens	% Control	%	82.0
Not Active	23327658	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	80.0	CHEMBL3935	Homo sapiens	% Control	%	80.0
Not Active	23328245	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	90.0	CHEMBL3935	Homo sapiens	% Control	%	90.0
Not Active	23328713	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23329253	CHEMBL4880960	Aurora-C(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	95.0	CHEMBL3935	Homo sapiens	% residual kinase activity	%	95.0
Not Active	23329659	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	67.0	CHEMBL3935	Homo sapiens	% Control	%	67.0
Not Active	23330127	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23330883	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	99.0	CHEMBL3935	Homo sapiens	% Control	%	99.0
Not Active	23331351	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23331938	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23332406	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	86.7	CHEMBL3935	Homo sapiens	% Control	%	86.7
Not Active	23333122	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23333761	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	92.0	CHEMBL3935	Homo sapiens	% Control	%	92.0
Not Active	23334229	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	94.0	CHEMBL3935	Homo sapiens	% Control	%	94.0
Not Active	23335208	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	72.0	CHEMBL3935	Homo sapiens	% Control	%	72.0
Not Active	23335676	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	97.0	CHEMBL3935	Homo sapiens	% Control	%	97.0
Not Active	23336303	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	91.0	CHEMBL3935	Homo sapiens	% Control	%	91.0
Not Active	23336771	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23337518	CHEMBL4881889	AURKC Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	93.0	CHEMBL3935	Homo sapiens	% Ctrl	%	93.0
Not Active	23337852	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23338320	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23338932	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	91.0	CHEMBL3935	Homo sapiens	% Control	%	91.0
Not Active	23339400	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	81.0	CHEMBL3935	Homo sapiens	% Control	%	81.0
Not Active	23340037	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23340505	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	92.0	CHEMBL3935	Homo sapiens	% Control	%	92.0
Not Active	23341162	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23341630	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23342246	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23342714	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23343344	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23343812	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	76.0	CHEMBL3935	Homo sapiens	% Control	%	76.0
Not Active	23344450	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	88.0	CHEMBL3935	Homo sapiens	% Control	%	88.0
Not Active	23345023	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	96.0	CHEMBL3935	Homo sapiens	% Control	%	96.0
Not Active	23345491	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	92.0	CHEMBL3935	Homo sapiens	% Control	%	92.0
Not Active	23346068	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23346537	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23347147	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23347628	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23348207	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23348675	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23349262	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	94.0	CHEMBL3935	Homo sapiens	% Control	%	94.0
Not Active	23349880	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23350348	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23350953	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23351421	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	78.0	CHEMBL3935	Homo sapiens	% Control	%	78.0
Not Active	23351967	CHEMBL4882660	AURKC (Aurora C) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	1.855	CHEMBL3935	Homo sapiens	% Inhibition	%	1.8546
Not Active	23352445	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23352913	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23353795	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	95.0	CHEMBL3935	Homo sapiens	% Control	%	95.0
Not Active	23354263	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	92.0	CHEMBL3935	Homo sapiens	% Control	%	92.0
Not Active	23354995	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	95.0	CHEMBL3935	Homo sapiens	% Control	%	95.0
Not Active	23355463	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23356099	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23356567	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23357176	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23357823	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23358291	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23358877	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	67.3	CHEMBL3935	Homo sapiens	% Control	%	67.3
Not Active	23359475	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	91.0	CHEMBL3935	Homo sapiens	% Control	%	91.0
Not Active	23359943	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	96.0	CHEMBL3935	Homo sapiens	% Control	%	96.0
Not Active	23360528	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23360996	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23361569	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23362105	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23362573	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23364215	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	87.0	CHEMBL3935	Homo sapiens	% Control	%	87.0
Not Active	23364683	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	97.0	CHEMBL3935	Homo sapiens	% Control	%	97.0
Active	23365422	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	9.0	CHEMBL3935	Homo sapiens	% Control	%	9.0
Not Active	23365965	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	98.0	CHEMBL3935	Homo sapiens	% Control	%	98.0
Not Active	23366555	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23367023	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23367476	CHEMBL4883829	Aurora-C ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	85.0	CHEMBL3935	Homo sapiens	% Residual activity with Skepinone-L	%	85.0
Not Active	23367901	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	81.0	CHEMBL3935	Homo sapiens	% Control	%	81.0
Not Active	23368369	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	87.0	CHEMBL3935	Homo sapiens	% Control	%	87.0
Not Active	23368968	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23369436	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23369981	CHEMBL4884225	Aurora-C(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	85.0	CHEMBL3935	Homo sapiens	% residual kinase activity	%	85.0
Slightly Active	23370404	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	29.0	CHEMBL3935	Homo sapiens	% Control	%	29.0
Not Active	23370872	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	97.0	CHEMBL3935	Homo sapiens	% Control	%	97.0
Not Active	23371681	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	98.0	CHEMBL3935	Homo sapiens	% Control	%	98.0
Not Active	23372149	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	78.0	CHEMBL3935	Homo sapiens	% Control	%	78.0
Not Active	23375576	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23376044	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23376622	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	97.0	CHEMBL3935	Homo sapiens	% Control	%	97.0
Not Active	23377091	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	90.0	CHEMBL3935	Homo sapiens	% Control	%	90.0
Not Active	23377949	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23378417	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23379584	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	94.0	CHEMBL3935	Homo sapiens	% Control	%	94.0
Not Active	23380052	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	88.0	CHEMBL3935	Homo sapiens	% Control	%	88.0
Not Active	23380746	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	98.0	CHEMBL3935	Homo sapiens	% Control	%	98.0
Not Active	23381394	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Not Active	23381862	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3935	Homo sapiens	% Control	%	100.0
Slightly Active	23382486	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	47.0	CHEMBL3935	Homo sapiens	% Control	%	47.0
Active	23382954	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	14.0	CHEMBL3935	Homo sapiens	% Control	%	14.0
Not Active	23383704	CHEMBL4887355	AURKC Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	95.0	CHEMBL3935	Homo sapiens	% Ctrl	%	95.0
Not Active	23384187	CHEMBL4887782	Aurora_C(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	4.64	CHEMBL3935	Homo sapiens	% inhibition	%	4.64
Not Active	23384869	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	77.0	CHEMBL3935	Homo sapiens	% Control	%	77.0
Not Active	23385336	CHEMBL4879593	KinomeScan assay: inhibition of AURKC	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	85.0	CHEMBL3935	Homo sapiens	% Control	%	85.0
